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Toxoplasma gondii is a master manipulator of the immune response, modulating 
proinflammatory cytokine production from host cells, blocking apoptotic pathways, 
and altering motility of infected cells. In these studies, I identify a Gr-1-expressing 
subset of dendritic cells hijacked by the parasite as a vehicle for dissemination from 
the inoculation site after intraperitoneal infection. These DC are preferentially infected 
compared to other cell types in the peritoneal cavity, and they migrate to the spleen in 
partial dependence on CCR2 signaling. Toxoplasma also suppresses TLR ligand-
stimulated IL-12 production from infected cells. Subsequently, I characterize the 
differences in recruitment and parasitization of cell types by different strains of 
Toxoplasma, demonstrating that the avirulent Types II and III strains lead to higher 
levels of CD11c-expressing DC at the infection site. Finally, I elucidate the cell 
populations targeted in the intestine and the mesenteric lymph nodes after oral 
inoculation. I find that in the mesenteric lymph nodes and Peyer’s patches, the cell 
types most strongly represented among infected cells are CD3+ or B220+ lymphocytes. 
However, the infection rate in these regions is highest in the cells expressing innate 
immune cell markers, such as Gr-1, CD11b, CD11c and 1A8/Ly6-G. Interestingly, 
infection in the lamina propria appears to be preferential for neutrophils, possibly 
indicating a role for neutrophils in dissemination of parasite during early oral 
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Toxoplasma gondii is a member of the protozoan phylum Apicomplexa, so named for 
their unique apical complex which executes a variety of functions for cellular invasion 
and intracellular survival. The phylum includes many obligate intracellular pathogens, 
the most clinically devastating of which is the genus Plasmodium, which causes 
malaria, as well as other coccidian pathogens such as Cryptosporidium.  T. gondii is 
the only species in its genus, and is an important organism in both human and 
veterinary medicine as the causative agent of disease in infants, immunocompromised 
populations and livestock.   
 
T. gondii was discovered in Tunisia in 1908 by Nicolle and Manceaux, isolated from 
Ctenodactylus gundi (1), and also in Brazil by Splendore (2).  It has since been found 
in a wide range of hosts (3-5), leading to the conclusion that the parasite can infect 
most birds as well as terrestrial and marine mammals. Recently, it has also been 
shown that oocysts taken up by Eastern oysters retain their infectivity for at least 85 
days, indicating that it may also persist in invertebrates (6). The parasite is capable of 
infecting virtually all nucleated cell types, though sexual reproduction of the parasite 
only occurs within enterocytes of felids (7). 
 
 The life cycle of Toxoplasma begins when a member of order Felidae ingests tissue 
cysts from the skeletal muscle of its prey, or oocysts from the environment (8). The 
cyst wall is readily digested in acid and proteolytic enzymes of the stomach, and the 
enzyme-resistant organisms, called bradyzoites in the case of tissue cysts (or 
sporozoites in the case of oocysts), are released (9). Within the cat intestine, asexual 
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stages of development occur, called types A-E, and gametogony proceeds afterward, 
leading to the production of oocysts containing sporozoites, which are shed in the 
feces (10).  The prepatent period for a cat infected with bradyzoites is 7-21 days (8), 
and they shed millions of oocysts during this time period. Once shed in the feces, 
oocysts become infective after 1-5 days (11) and can remain infectious for several 
months once sporulation occurs (12). Oocysts are hardy, resistant to harsh 
environmental conditions including cold (13) and saltwater (14). During infection of 
intermediate hosts, bradyzoites do not begin sexual reproduction in the epithelial cells, 
and instead multiply in the lamina propria as tachyzoites. Tachyzoites disseminate out 
of the intestine and spread throughout the body, invading and replicating inside 
nucleated host cells (15-17).  
 
Toxoplasma is an obligate intracellular parasite, taking up residence in host cells for 
nutrient provision as well as protection from certain elements of the immune response. 
Entry into host cells is accomplished by a mechanism dependent on both parasite and 
host actin (18-19) in which specialized organelles specific to T. gondii’s 
Apicomplexan classification play  distinct,  sequential  roles. The  micronemes  release  
proteins to adhere to the host surface, and the rhoptries release proteins from the 
parasitophorous vacuole (PV) (20). A ring-shaped point of contact between the 
parasite and host cell, called the moving junction, moves from the anterior to the 
posterior of the parasite, pulling the host cell plasma membrane over the organism and 
excluding host transmembrane proteins to form the PV (16-17). Host membrane 
proteins are excluded and proteins from the rhoptries and dense granules insert into the 
PV membrane, rendering the vacuole nonfusigenic. Therefore, the parasite is protected 
4 
 
Figure 1.1. Life cycle of Toxoplasma gondii. A member of family Felidae ingests 
tissue cysts in the skeletal muscle or brain of a prey animal. Bradyzoites are released 
after digestion of the cyst wall, and gametogenesis takes place in the intestine. 
Unsporulated oocysts are shed in the feces and sporulate in the environment, where 
they remain infective for months. Humans and other intermediate hosts become 
infected by ingestion of oocyst-contaminated food such as unwashed vegetables, tissue 
cysts in undercooked meat, or by transplacental transmission.  
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from lysosomal fusion and acidification (17, 21). Studies to clarify how the parasite 
acquires nutrients from the host cell, however, have revealed that the parasite is not 
entirely sequestered from endo-lysosomal components. Within the PV, dense granule 
proteins are involved in the formation of a tubulovesicular network (TVN) (22). 
Endocytic vesicles from the host travel along microtubules to the PV, where the 
microtubules create invaginations in the PVM that are likely elongated by TVN lipids. 
Vesicles enter the vacuolar space via these invaginations, and are pinched off and 
sequestered within this location. In this way, the parasite can acquire many nutrients of 
low molecular weight (23). Toxoplasma also recruits host endoplasmic reticulum and 
mitochondria, possibly to obtain phospholipids and lipoic acid (24-25), and pores in 
the membrane allow passive diffusion of small molecules (26).  
 
After invasion, tachyzoites replicate within the parasitophorous vacuole by 
endodyogeny, with a doubling time of approximately 7 hours (27), and eventually lyse 
the host cell and enter neighboring cells. Dendritic cells and monocytes have been 
implicated as vehicles for parasite dissemination to various organs and eventually to 
the central nervous system (27-28). It is hypothesized by some that upon sufficient 
pressure by IFN-γ-mediated immunity, tachyzoites begin to express bradyzoite 
antigens, undergoing stage conversion to quiescent tissue cysts which may persist for 
the lifetime of the host.  
 
Three clonal lineages encompass the majority of T.gondii strains in Europe and North 
America, and they differ genetically by less than one percent. Type I is identified most 
commonly in immunocompetent patients who exhibit ocular disease, even though 
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Type II strains make up most cases of infection in humans. (29-30) Several 
characteristics of Type I strains may explain their enhanced virulence, including a 
greater ability to migrate over long distances and penetrate lamina propria and 
submucosa, tissues that they would encounter early in the host (31). Additionally, 
Type I parasites exhibit enhanced growth capability compared with Types II and III, 
leading to much higher parasite burden, which triggers high levels of Th1 cytokines 
and immunopathology (32, 33). Two virulence factors responsible for these 
differences have recently been identified as the kinases ROP16 and ROP18, rhoptry 
proteins with allelic variation between the strain types (34-35). Distinctions in parasite 
manipulation of host cytokine production have also been observed, including 
elicitation of higher levels of IL-12 from macrophages by type II parasites compared 
to types I and III (36-37). Type I induction of IL-12 is MyD88-independent, whereas 
Type II uses both MyD88-dependent and independent pathways (37). Type I parasites 
also elicit more neutrophils to the infection site after intraperitoneal inoculation than 
do Type II, which primarily induce Gr-1+ monocyte recruitment, and are more 
frequently found within neutrophils as well (38). Further characterization of the 
differences between infection with these strain types remains a topic of investigation.  
 
Clinical Relevance 
T. gondii infects about 9% of the United States population, but seroprevalence in other 
nations can be much higher (39-40). Worldwide prevalence of Toxoplasma infection is 
variable, and in some countries, such as Panama, seroprevalence by the age of 60 is as 
high as 90% (41). Risk factors for acquiring T. gondii include eating undercooked 
meat and unwashed vegetables, and cohabitation with felines. T. gondii is important in 
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both human and veterinary medicine, as a foodborne illness affecting humans with 
weakened immune systems, and a leading cause of abortion in livestock (42-43).   
 
Transmission of T. gondii to intermediate hosts, including humans, can occur via three 
routes: fecal-oral, congenital, and carnivorism. Disease manifestation in humans can 
take a number of forms, depending upon the parasite strain, immune status of the 
patient, and route of acquisition. The most common symptom present in 
immunocompetent patients is lymphadenopathy (44), and infection is often 
subclinical. Ocular toxoplasmosis, present in approximately 2% of infected individuals 
in the United States (45), is characterized by recurring retinochoroiditis. The risk of 
developing ocular disease from T. gondii infection is higher in those infected 
congenitally, though postnatally acquired infection occasionally leads to this outcome 
as well (45). While most human infections are comprised of Type II strains, it has 
been suggested that Type I T.gondii is more likely to cause ocular toxoplasmosis in 
immunocompetent patients (29). In addition to ocular symptoms, the other three 
classic symptoms of congenital transmission include hydrocephalus, convulsions, and 
intracerebral calcifications (46). Consequences of postnatal infection are usually mild 
to subclinical, but immunocompromised individuals who are chronically infected can 
suffer reactivation of cysts in the brain, leading to inflammation and the cerebral 
lesions that characterize toxoplasmic encephalitis (TE) (42). This is a common 
opportunistic disease for AIDS patients, as one study showed the incidence of TE in 
this population at 15.9% over a one-year period (47). Patients with TE may experience 
neurological symptoms such as disorientation and convulsions, eventually leading to 
death (42).  
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Diagnosis of T.gondii can be achieved by several methods, including serology, PCR 
and histology. The original diagnostic tool for serology was the Sabin-Feldman 
methylene blue dye test (MBDT), which tests for the presence of antibodies in serum 
that can permit complement-mediated killing of tachyzoites. Because of the 
requirement for live parasites, however, this method is comparatively uncommon for 
routine testing. (48). Blood tests are available for IgM, IgA and IgG antibodies, such 
as enzyme-linked immunosorbent assay (ELISA), HS/AC differential agglutination 
test and IgM-immunosorbent agglutination assay, and indirect fluorescent antibody 
test (IFAT) (49-53). The IgG avidity test, an ELISA technique that utilizes urea to 
break the antibody-antigen bond, allows determination of whether an infection is 
primary or a result of reactivation (54-55), and PCR for the B1 gene of T.gondii is 
useful for detecting the parasite directly in cases where immune-based tests are 
unreliable, such as during advanced HIV infection (56). Serological detection of 
congenital toxoplasmosis is currently imprecise, as a recent study indicated that 
absence of IgM and IgA antibodies by enzyme-linked fluorescence assay, 
microparticle enzyme immunoassay and immune-fluorescent antibody technique was 
less than 50% accurate for predicting whether an infant was infected (57). PCR 
analysis of amniotic fluid, however, gives over 90% accuracy, and is currently the best 
method to diagnose congenital infection (58).  
 
The most common treatment for toxoplasmosis uses pyrimethimine in combination 
with sulfadiazine and folinic acid, with clindamycin occasionally used as a substitute 
for patients who cannot tolerate the sulfonamide family of drugs. Treatment lasts from 
four to six weeks, or until symptoms are no longer detectable (59). However, 
hypersensitivity to the drugs remains a problem, and safer methods of treatment 
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remain a topic of study. Treatment to prevent vertical transmission and to treat ocular 
symptoms postnatally are less well-characterized, and further study will be needed to 
elucidate effective approaches for reducing both transmission and disease.  
 
Vaccination against the parasite is currently under development, and several 
approaches have been tested for felines, livestock and humans. However, expense can 
be a limiting factor, such as with a successful vaccine for cats, T-263. A live 
bradyzoite mutant, T-263, prevented kittens from shedding oocysts when delivered 
orally, but was expensive and difficult to transport and maintain (60). A vaccine 
consisting of crude rhoptry proteins and the adjuvant Quil-A did diminish oocyst 
shedding in cats (61). Successful vaccines in livestock such as ewes, goats and pigs 
have been elusive, as even the licensed Toxovax vaccine, a live vaccine using strain 
S48 for sheep, carries the risk of reverting to a virulent strain (62). A DNA vaccine in 
pigs, though it did not confer strong protection, induced Th1 and humoral immunity to 
T.gondii, indicating that DNA vaccines will be an avenue worth pursuing (63). As for 
human vaccines, promising candidates have come from studies of rats and mice, 
utilizing SAG-1 as well as various microneme, rhoptry and dense granule antigens via 
crude protein or DNA vaccination, leading to partial protection (64-66). Recently, it 
has been shown that exosomes elicited from T.gondii-antigen-pulsed dendritic cells 
are capable of conferring protection against both primary (67-68) and congenital 






The immune response to T.gondii is cell-mediated, depending on the critical 
proinflammatory cytokines IL-12, TNF-α and IFN-γ. The response can be divided into 
two stages corresponding with the two stages of infection in the intermediate host. The 
first wave of immunity aims to control replication and drive the parasite into latency, 
while the second phase keeps reactivation of encysted T.gondii in check. Anti-
inflammatory responses are also produced to control immunopathology, thereby 
maintaining a balance between successful parasite migration to the sites of latency and 
survival of the host. 
 
Immunity in the acute phase is initiated through recognition of tachyzoites by innate 
immune cells such as dendritic cells, macrophages and neutrophils, which are capable 
of sensing parasite via a number of surface receptors. TLRs 2 and 11 have been shown 
to recognize parasite products, leading to distinct responses. Recognition of 
glycophosphatidylinositols by TLRs 2 and 4 leads to NF-κB activation and TNF-α 
production by macrophages (70), and the TNF response from macrophages is 
completely abolished only when both of these receptors are absent (71). Toxoplasma 
stimulation of TLR2 is also necessary for induction of nitric oxide by macrophages 
(72). TLR11 recognizes the profilin-like molecule TgPRF on tachyzoites (73), 
eliciting IL-12 from dendritic cells in vitro and from splenocytes in vivo. G-protein 
coupled receptors are also capable of recognizing parasite molecules in order to mount 
proinflammatory responses, such as in the case of the splenic CD8α+ subset of DCs, 
which produce IL-12 in response to CCR5 ligation by the Toxoplasma-secreted 
molecule cyclophilin C-18 (74). Additionally, pertussis toxin treatment abolishes 
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residual STAg-induced IL-12 in CCR5-/- splenocytes, possibly implicating other 
GPCR pathways in recognition of the parasite (75).  
 
IL-12 produced by innate immune cells activates natural killer cells to produce IFN-
γ (76), which signals through STAT1 to activate microbicidal mechanisms in 
macrophages (77). Indeed, mice lacking STAT1 have increased susceptibility to 
infection, indicating a role for these mechanisms in host defense (78-79). The most 
important microbicidal effect during acute infection appears to be activation of p47 
GTPases, which have been shown to control parasite growth in vitro. Recently, the 
mechanism of this control was elucidated, in that these molecules disrupt the 
membrane of the parasitophorous vacuole by vesiculation, ultimately leading to its 
destruction and degradation of the parasite (80-81).  
 
While neutrophils are well-known killers of microbes via reactive oxygen 
intermediates, there is little evidence to show that they play this role during T.gondii 
infection. In vitro studies have shown that macrophages use nitric oxide to kill 
tachyzoites after activation by IFN-γ (82). However, studies using gene knockout mice 
have shown that iNOS is not necessary for host survival during the acute phase in 
mice. This leads to the conclusion that in mice, nitric oxide is likely not a critical 
mechanism by which parasite replication is controlled (83).  
IFN-γ also acts on innate immune cells to stimulate greater production of IL-12 (84), 
which along with antigen presentation from dendritic cells, activates CD4+ helper T 
cells (85). CD4+ T cells differentiate into Th1 cells to produce IFN-γ and IL-2, and 
help activate CD8+ T cells. CD4+ and CD8+ T cells both contribute to the IFN-γ levels 
12 
at sites of infection (86). Destruction of cells by perforin has been shown to be 
dispensable in controlling parasite growth (87), indicating that IFN-γ production is 
likely the critical component of T cell involvement during the acute phase of infection.  
 
Chronic infection is characterized by quiescent tissue cysts in the skeletal muscle and 
central nervous system of the host. Depletion of CD4+ and CD8+ cells in mice leads to 
reactivation of the parasite and toxoplasmic encephalitis (86, 88), which reflects 
observations in AIDS patients and indicates an important role for these T cells in 
maintaining quiescence. This requirement for T cells is likely due in part to cytolytic 
activity by parasite-specific CD8+ T cells, which have been demonstrated to contribute 
to survival during the chronic phase of Type II infection as well as reduced cyst counts 
in the brain (87). IFN-γ-triggered mechanisms of parasite control have also shown to 
be important at this stage, given that deficiency in iNOS, which is upregulated by IFN-
γ signaling through STAT1, is lethal during chronic infection (83), and murine 
astrocytes can kill intracellular parasites in vitro dependent on IGTP, a p47 GTPase 
(89). Therefore, immunity during the chronic phase of infection combines both cell-
mediated and soluble factors for parasite killing and prevention of recrudescence.  
 
In addition to stimulating a Th1-biased host response, T.gondii also triggers anti-
inflammatory cytokines to control immune pathology. Knockout studies with the anti-
inflammatory cytokine IL-10 showed that mice die of massive inflammation during 
infection, mediated by CD4+ T cells (90). Interestingly, effector CD4+ T cells have 
also been found to be a major source of IL-10 (91), although whether they are the 
critical source remains to be seen, considering that other cell types also produce this 
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cytokine during infection (92). During chronic infection, parasite triggering of lipoxin 
A4 production has been shown to dampen the immune response due to downregulation 
of CCR5 on dendritic cells and therefore diminished stimulation of proinflammatory 
cytokine production (93-94). Finally, in the absence of IL-27R, Th17 cells emerge and 
cause pathology during chronic infection (95), indicating that IL-27 signaling is also 
an important mechanism for suppressing immune pathology. 
 
Toxoplasma Evasion of Host Response 
Toxoplasma has developed a number of methods to escape host immunity, largely 
involving alteration of intracellular signaling pathways within the cells it has invaded 
in order to suppress inflammation and parasite recognition. A major consequence of 
this intracellular signaling manipulation is the suppression of TLR-triggered cytokine 
production. In vitro studies in macrophages have demonstrated the parasite’s ability to 
block translocation of NF-κB to the nucleus, interfering with cellular production of IL-
12 and TNF-α (96). While IL-12 production is restored after the block is lifted, TNF is 
still suppressed. Recent work has more fully elucidated a mechanism of TNF-α 
blockage by T.gondii, showing that the parasite blocks histone modification at the 
TNF promoter, preventing binding of transcription factors (97). Another mechanism 
of parasite-mediated cytokine suppression was found to be Toxoplasma’s ability to 
exploit the host’s natural anti-inflammatory mechanisms, such as the IL-10/STAT3 
signaling pathway. Upon infection of bone-marrow-derived macrophages, T.gondii 
rapidly induces phosphorylation of STAT3, typically associated with the IL-10 
signaling cascade, independently of this cytokine. STAT3 phosphorylation suppresses 
the ability of the cells to produce IL-12 and TNF-α when stimulated with 
lipopolysaccharide (98). Toxoplasma is also capable of deactivating mitogen-activated 
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protein kinases (MAPK) and rendering macrophages resistant to subsequent activation 
by LPS, leading in turn to diminished production of IL-12 and TNF-α (99).  
 
Toxoplasma not only dampens proinflammatory cytokine production, but also works 
to disable macrophages’ microbidical capabilities by partially inhibiting production of 
nitric oxide via downregulation of iNOS (100-101). In addition to downregulating the 
expression of nitric oxide synthase, the parasite also diminishes antigen-presenting 
capability by reducing MHC Class II expression and preventing upregulation of Class 
I in macrophages (102-103), and prevents maturation of parasitized immature 
dendritic cells (104). In these ways, Toxoplasma helps maintain the balance between 
an immune response robust enough to keep the host alive, but limited enough that the 
parasite can survive to the chronic phase of infection.  
 
In addition to modulation of innate immune cell signaling pathways to control 
inflammation, several studies have suggested that Toxoplasma uses various cell types 
to remain sequestered from host immunity and assist its dissemination throughout the 
host. Toxoplasma shuts down apoptotic pathways in parasitized cells by interfering 
with mitochondrial cytochrome c release, thereby diminishing the activation of the 
caspase cascade, as well as through activation of the Gi-dependent PI 3-kinase 
pathway and phosphorylation of protein kinase B (105-106). By inhibiting apoptosis, 
T.gondii may remain sequestered from extracellular immune mechanisms. Studies 
noted that natural killer cells are targeted for infection after killing infected dendritic 
cells, which become hypersensitive to NK-mediated lysis compared to uninfected DC. 
Newly-parasitized NK cells are resistant to killing by other NK cells and lack 
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intracellular microbicidal mechanisms, which may make them an ideal reservoir for 
parasites (107). Dendritic cells themselves have also been implicated as reservoirs and 
vehicles for dissemination. In vitro work with bone-marrow-derived DC showed that 
Toxoplasma invades immature dendritic cells more efficiently than mature DC, and 
blocks their ability to produce IL-12 and TNF-α in response to TLR ligands and 
CD40L, as well as diminishing their ability to activate naïve CD4+ T cells (104). In 
vivo studies have also indicated a role for DC in dissemination of Toxoplasma. After 
intragastric inoculation with a low dose of cysts, parasitized CD11c+ and CD11b+ cells 
were able to cross the blood-brain barrier, indicating that they could deliver parasites 
to the brain (27), and tachyzoites induce hypermotility in dendritic cells in vitro both 
in culture and after transfer into mice (28). Recently, the ability of T.gondii to 
effectively utilize dendritic cells for transport has been suggested to be dependent on 
the parasite genotype (108). Combined with the ability of the parasites to 
downmodulate cytokine production and MHC Class II expression, the possibility 




Dendritic cells are professional antigen-presenting cells that bridge the gap between 
innate and adaptive immunity by providing costimulation and antigenic peptide in the 
context of MHC Class I and II to T cells. First described in 1973 by Ralph Steinman 
and Zanvil Cohn, they were soon demonstrated to be the splenic accessory cells 
required for activation of adaptive immune responses, capable of stimulating a mixed 
leukocyte response up to 300 times stronger than total splenic cells (109). Several 
subtypes of dendritic cell are recognized, defined by location, lineage, cell surface 
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molecules, and function. Broadly, dendritic cells can be classified as cDCs 
(conventional DCs) or pDCs (plasmacytoid DCs). Immature DCs are present in the 
blood, peripheral tissues and lymphoid organs, and display low motility and high 
phagocytic capacity (110-111). Upon encounter with microbial or inflammatory 
stimuli such as Toll-like receptor ligands, dendritic cells become mature, upregulating 
costimulatory molecules such as CD80 and CD86, as well as Class II MHC. They 
acquire high motility and lose their phagocytic activity, migrating to secondary 
lymphoid organs to present antigenic peptides to T cells (111-117). They are also 
capable of producing cytokines important to immunity, such as IL-12, TNF-alpha, IL-
10 and others (111, 118-119). Additionally, oxygen-dependent microbicidal activity 
has been observed in IFN-γ-activated dendritic cells during T. gondii infection (120).  
 
In recent years, the role of Ly6C-expressing dendritic cells in infection has come to be 
appreciated through the recognition of plasmacytoid dendritic cells (pDC) and 
monocyte-derived DCs (mDC). Plasmacytoid dendritic cells are a unique type of DC 
that serve multiple functions for immunity depending on the maturation state. As 
interferon-producing cells (IPC) with characteristic plasma cell morphology, pDCs 
respond to microbial signaling through TLR7 and TLR9, rapidly producing large 
quantities of Type I interferon (121-123), which leads to maturation of monocytes and 
antigen presentation (124-125), as well as activation of natural killer cells (126). 
Maturation of monocytes induced by pDC-produced Type I IFNs leads to 
proinflammatory cytokine production and ability to cross-prime CD8+ T cells (124, 
127). Sequential production of interferon-α and IL-6 by pDCs also leads to plasma 
cell differentiation (128). Autocrine signaling by Type I interferons, as well as 
microbial stimuli, trigger interferon-producing pDCs to mature into an activated state 
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more closely resembling cDC (129-130). The mature phenotype includes expression 
of typical DC activation markers, such as high levels of MHC Class II, CD40, CD80 
and CD86. Matured pDCs also exhibit functions in common with conventional DCs, 
including ability to respond to TLR4 stimulation, produce IL-12, and present antigen 
(129-131). In recent years, roles for pDCs in non-viral infections have been elucidated. 
Most notably, pDCs produce IFN-α and IL-12 after TLR11 stimulation with the 
profilin-like molecule of T.gondii, and are also capable of presenting Toxoplasma 
antigen in the context of MHC Class II (132).  
 
Monocyte-derived DCs arise from Ly6C+ inflammatory monocytes, which circulate in 
the blood with the phenotype Gr-1+CCR2+CX3CR1low (133), are recruited to sites of 
infection by CCR2 (134-135), and differentiate into macrophages and dendritic cells 
(133, 136-137). Cells of this lineage play a key role in Toxoplasma infection, as 
inflammatory Gr-1+ monocytes expressing the macrophage marker CD68 are 
important during the acute stage of infection for controlling parasite growth at the 
inoculation site, and also produce IL-12 and nitric oxide (38). Monocytes that have 
differentiated into dendritic cells have also been shown to play important roles in 
infection with other intracellular pathogens. During infection with Listeria 
monocytogenes, for example, monocyte-derived dendritic cells accumulate in the 
spleen, producing TNF-alpha and upregulating iNOS in order to clear bacteria.  Due to 
their TNF and iNOS-dependent functions, they have been designated “TipDCs” (138). 
Recruitment of these cells to the spleen is dependent on CCR2 signaling. TipDCs are 
also critical for expansion of pathogen-specific CD8+ T cells during influenza 
infection (139). Recruitment of inflammatory DCs to the lymph nodes has also been 
observed during virus infection in dependence on CCR2, producing high levels of IL-
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12 and triggering strong activation of CD4+ T cells, demonstrating a role for 
inflammatory DCs in T cell priming (140). Interestingly, it has been observed that 
under inflammatory conditions during infection with lymphocytic choriomeningitis 
virus, cells with a phenotype corresponding to plasmacytoid DCs undergo a shift in 
surface markers to downregulate B220, Ly6C and CD8, and upregulate CD11b and 
CD11c, thereby acquiring a phenotype similar to myeloid DCs. These cells shift 
functionally as well, becoming newly capable of responding to TLR4 stimulation by 
IL-12 production (141). This phenotypic and functional plasticity, in addition to 
evidence that pDCs and mDCs derive from a common precursor (142), suggests that 
the delineation between the pDC and mDC subsets is perhaps not as definitive as it 
once seemed.   
 
Outline of Dissertation Research 
Previous work in our laboratory on early immune responses to Toxoplasma led me to 
ask the question of which cells were parasitized during early acute infection. I utilized 
an intraperitoneal model of Type I infection so as to control the dose of tachyzoites 
more precisely, since infection with cysts can lead to irregularities based on cyst size. 
Chapter 2 details the findings of these initial experiments, in which I discovered that 
while most cell types were parasitized by tachyzoites at the infection site, a certain 
population of CD11c+Gr-1+ cells were more susceptible to infection than the rest. I 
found that cells expressing this phenotype also comprised the majority of infected 
cells in the spleen at day 4 post-infection, and they expressed a number of markers 
related to antigen-presenting cells and plasmacytoid dendritic cells. I showed that the 
infected CD11c+Gr-1+ cells are capable of migrating from the peritoneal cavity to the 
spleen using an adoptive transfer model with congenic mice, and that this migration is 
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partially dependent on the presence of CCR2. Finally, I showed that cells isolated 
from infected mice and stimulated with TLR ligands are capable of producing IL-12, 
but are suppressed in this function when parasitized. I concluded that T.gondii targets 
CD11c+Gr-1+ cells at the infection site, suppresses their effector function, and uses 
them as Trojan horses for dissemination throughout the body.  
 
Chapter 3 describes the continuation of this work using representative strains of the 
three major clonal lineages of Toxoplasma, Types I, II and III. Peritoneal exudate cells 
and splenocytes were isolated on days 3 and 5 post-infection, and cell surface 
phenotype and presence of parasites were examined by flow cytometry. I found that 
while CD11c+Gr-1+ cells were parasitized in the spleens of Type II and Type III-
infected mice, they were not the majority of infected cells, indicating that the 
preference of the parasite for this cell type is less strong than with Type I. In the 
peritoneal exudates, the majority of infected cells were Gr-1+ during Type I infection, 
and CD11c+ during infection with Types II and III. Furthermore, the percentage of 
cells expressing CD11c+ was significantly higher in the mice infected with less 
virulent strains, as was the percentage of CD8+ cells and Siglec H+ cells. Given the 
relative speed of Type I replication and cell lysis compared to Types II and III, this 
variation in levels of DC and neutrophils may not indicate a difference in which cells 
are being targeted, but in how quickly the targeted cells are killed.  
 
Chapter 4 examines the early targets of infection using oral inoculation with Type II 
cysts. While the intraperitoneal model allows us to easily recover cells from the site of 
inoculation and to control the parasite dose, the oral model gives a more accurate view 
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of how natural infection proceeds, as most infection is acquired through ingestion of 
tissue or oocysts. To address the question of which cells T.gondii targeted during oral 
infection, I harvested several tissues that would be encountered early on, such as the 
lamina propria, the Peyer’s patches, and the mesenteric lymph nodes. My results 
showed that two populations comprised the majority of infected cells in the lamina 
propria: cells expressing B220, though not the B cell marker CD19, and cells 
expressing the neutrophil marker 1A8. In the Peyer’s patches, most infected cells were 
B220+, and in the mesenteric lymph nodes, CD3+ and B220+ cells were the dominant 
cell populations parasitized. These findings suggest that the phenomenon we observed 
during intraperitoneal infection, in the hypersusceptibility of CD11c+Gr-1+ cells to 
infection and the hijacking of these cells as Trojan horses, may not be a phenomenon 
that occurs during oral infection. Finally, Chapter 5 summarizes these results and 
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 DENDRITIC CELLS EXPRESSING PLASMACYTOID MARKER PDCA-1 








*This chapter reproduced, with permission, from the paper “Dendritic Cells 
Expressing Plasmacytoid Marker PDCA-1 are Trojan Horses During 
Toxoplasma gondii Infection”, by AL Bierly, WJ Shufesky, W Sukhumavasi, AE 
Morelli and EY Denkers, published in 2008 in the Journal of Immunology, 






Plasmacytoid dendritic cells (pDCs) play a key role in the innate immune response to 
viral infection, due largely to their ability to produce large quantities of type I IFNs. 
These cells are also notable for their ability to differentiate into conventional dendritic 
cells after appropriate stimulation. Here, we show that a splenic population of murine 
CD11c+ cells expressing pDC markers Gr-1, B220, and PDCA-1 is preferentially 
parasitized after infection with the virulent RH strain of Toxoplasma gondii. Although 
these markers are closely associated with pDCs, the population we identified was 
unusual because the cells express CD11b and higher than expected levels of CD11c. 
By adoptive transfer of CD45.1-positive cells into CD45.2 congenic mice, we show 
that CD11c+Gr-1+ cells migrate from the peritoneal cavity to the spleen. During 
infection, these cells accumulate in the marginal zone region. Recruitment of infected 
CD11c+Gr-1+ cells to the spleen is partially dependent upon signaling 
through chemokine receptor CCR2. Intracellular cytokine staining demonstrates that 
infected, but not noninfected, splenic CD11c+Gr-1+ dendritic cells are suppressed in 
their ability to respond to ex vivo TLR stimulation. We hypothesize 
that Toxoplasma exploits pDCs as Trojan horses, targeting them for early infection, 




Toxoplasma gondii is an intracellular protozoan known for its ability to induce strong 
Th1-type cytokine responses (1). IL-12 and IFN-  are required to survive acute and 
chronic infection with this opportunistic pathogen, but overproduction of 
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these cytokines can precipitate proinflammatory pathology that results in host death 
(2, 3, 4, 5, 6, 7). Therefore, there is a need to tightly regulate Th1 cytokine production 
to allow parasite control without causing host death. Early events in initiation of 
immunity toToxoplasma are likely to play a prominent role in determining the strength 
and pattern of cytokine production during infection. 
 
Dendritic cells (DCs) are now recognized as central in immune response initiation, due 
to their ability to acquire Ag, migrate from peripheral tissues to lymphoid organs, 
activate naive T cells, and secrete immune-polarizing cytokines such as IL-12. DC 
biology is complex insofar as there are many distinct subpopulations with discrete 
phenotypic characteristics and functional activities (8, 9). Broadly, DCs can be 
subdivided into conventional DCs and type I IFN-producing plasmacytoid DCs 
(pDCs). Conventional DCs can be further subdivided based upon tissue 
localization and surface marker expression. Furthermore, other types of DCs arise in 
inflammatory or infection conditions, such as the TNF- and inducible NO synthase-
expressing DCs that emerge during mouse infection with Listeria monocytogenes and 
monocyte-derived DCs that appear at the infection site during Leishmania 
major infection (10, 11, 12). 
 
DCs are required to survive infection with T. gondii as shown in a recent study where 
diptheria toxin was used to deplete cells expressing the diptheria toxin receptor under 
the control of the CD11c promoter (13). Older studies showed that CD8 + DCs in the 
spleen are an important IL-12 source after i.v. injection of parasite lysate Ag (14). The 
identification of a Toxoplasma profilin molecule that induces high level IL-12 
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production from splenic DCs through activation of TLR11 provides a 
molecular explanation for this effect (15). Unexpectedly, it was recently reported that 
pDCs, which are usually associated with responses to viruses, acquire T. gondii-
derived Ag and produce IL-12 during infection with this parasite (16). At the same 
time, other studies provide evidence that DC infection with Toxoplasma down-
modulates their capacity to produce IL-12 (17). Discrepancies in how these cells 
respond to infection may result from using different DC subsets, or they may reflect 
differences in DC responses to extracellular parasite molecules vs their inherent ability 
to produce cytokines after parasite infection. 
 
In addition to their role in initiation of immunity to Toxoplasma, there is evidence that 
DCs serve as vehicles for dissemination during infection. During early oral infection, 
infected CD11c+ cells were identified in the lamina propria, Peyer’s patches, and 
mesenteric lymph nodes, although CD11c–CD11b+ cells were also found to be a 
reservoir of infection at these locations (18). Interestingly, another study reported that 
infection of human monocyte-derived DCs as well as mouse bone marrow-
derived DCs induce a state of hypermotility that, at least in mice, potentiates 
dissemination in the host (19). Therefore, it is seemingly paradoxical 
that Toxoplasma may target for infection cells that themselves play a predominant role 
in triggering anti-parasite immunity. 
 
To gain insight into in vivo interactions between DCs and Toxoplasma, and to 
determine the functional consequences of intracellular infection in an in vivo situation, 
we examined recruitment andinvasion of DCs during the early immune response. We 
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chose to use an i.p. infection model so that we could precisely control delivery of 
parasites and examine early cell recruitment and invasion at the site of infection. Most 
of the infected cells in the peritoneal cavity expressed monocyte/macrophage and 
neutrophil markers. In striking contrast, in the spleen the major population of infected 
cells was largely restricted to a subset that expressed surface markers most closely 
associated with pDCs. These cells were present as a minor population in the peritoneal 
cavity, but they were markedly more susceptible to infection compared with other cell 
types. We examined cytokine production by these cells and found that infected DCs’ 
ability to produce IL-12 was suppressed, whereas the corresponding 
noninfected population was capable of producing this cytokine. We hypothesize that T. 
gondii targets pDCs for early infection and dissemination, in the process inhibiting 
their ability to produce IL-12. 
 
Materials and Methods 
Mice 
Female C57BL/6 mice 6–8 wk of age were purchased from Charles River Laboratories 
and Taconic Farms. CCR2–/–, CCR5–/–, and control B6.129 mice were purchased from 
The Jackson Laboratory. CD45.1 C57BL/6 background congenic mice (strain B6.SJL-
Ptprca Pepcb/BoyJ) were maintained as a breeding colony at the Cornell College of 
Veterinary Medicine Animal Facility and were provided by Dr. J. Appleton (James A. 
Baker Institute for Animal Health, Ithaca, NY). The animals were housed in the 
Cornell University College of Veterinary Medicine transgenic mouse core facility, 
which is accredited by the American Association for Accreditation of 
Laboratory Animal Care. 
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Parasites and infections 
Tachyzoites of the RH strain were originally purchased from the American Type 
Tissue Collection, and a transgenic RH strain expressing tandem copies of yellow 
fluorescence protein (RH-YFP) was a gift from D. Roos (University of Pennsylvania, 
Philadelphia, PA) and B. Striepen (University of Georgia, Athens, GA). Parasites were 
maintained by passage in human foreskin fibroblasts in DMEM (Mediatech) 
supplemented with 1% bovine growth serum (HyClone), 100 U/ml penicillin and 100 
µg/ml streptomycin (Invitrogen). Infections were accomplished by i.p. injection of 
106 tachyzoites in 100 µl of PBS. 
 
Flow cytometric analysis 
Splenocytes were prepared by mechanical disruption of whole spleens, and red cells 
were lysed using red cell lysis buffer (8.3 g/L ammonium chloride in 0.01 M Tris-HCl 
buffer; Sigma-Aldrich). Splenocytes and peritoneal exudate cells were filtered 
through 70 µm filters, and incubated on ice for 15 min with 10% normal mouse serum 
in FACS buffer (1% BSA and 0.05% sodium azide in PBS). Surface staining was 
performed for 30 min on ice, and intracellular cytokine staining was performed using 
the BD Cytofix/Cytoperm fixation/permeabilization solution kit (BD Pharmingen). 
Cellswere stained with the following Ab obtained from BD Pharmingen: anti-CD11c 
allophycocyanin (clone HL3), anti-Gr-1/Ly6G PerCP (clone RB6-8C5), anti-CD4 PE 
(clone RM4-5), anti-B220 PE (clone RA3-6B2), and anti-IL-12p40 PE (C15.6). The 
following Abs were obtained from eBioscience: anti-CD40 PE (clone 1C10), anti-
B7.1 PE (clone 16-10A1), anti-B7.2 PE (GL1), anti-CD3 PE (145-2C11), anti-CD11b 
PE (clone M1/70), anti-MHC class II PE (clone M5/114.15.2), anti-CD8 PE (clone 53-
47 
6.7) and anti-CD45.1 PE (clone A20). Anti-mPDCA-1 PE (clone JF05-1C2.4.1) was 
purchased from Miltenyi Biotec, and anti-T. gondii p30 FITC (clone G-II9) from 
Argene. Cells were analyzed using CellQuest software and a FACSCalibur 
cytometer (BD Biosciences). 
 
Adoptive transfer of peritoneal exudate cells 
Peritoneal exudate cells were harvested from CD45.1 congenic mice on day 3 after i.p. 
inoculation with 106 RH-YFP tachyzoites, and 1.5 x 107 cells were injected i.p. into 
C57BL/6 mice that had been infected on the same day with the same dose of RH-
YFP parasites as the donor mice. After 48 h, peritoneal cells and splenocytes were 
harvested, and presence and phenotype of CD45.1 cells in the spleen were analyzed by 
flow cytometry. 
 
In vitro culture and analysis of splenic DCs 
Splenocytes were harvested from mice 4 days after infection with RH-YFP 
tachyzoites. DCs were enriched using pan-DC microbeads according to the 
manufacturer’s instructions (Miltenyi Biotec). The cells were subsequently incubated 
for 24 h with or without Escherichia coli LPS (Sigma-Aldrich) and CpG 
oligodinucleotide 1826 (Coley Pharmaceutical Group), including Golgi-Stop 
(BDPharmingen) for the last 4 h of incubation. The DC-enriched population was 




To visualize morphology of infected cells, splenocytes were harvested from mice 
infected i.p. 4 days earlier with RH-YFP tachyzoites and stained (as described above 
for FACS analysis) with anti-Gr-1 PE (BD Pharmingen). Cells were transferred to a 
glass slide via cytospin (Shandon), and nuclei were labeled with 4',6'-diamidino-2-
phenylindole (DAPI) (Invitrogen, Molecular Probes). Staining of spleen sections from 
infected mice was performed as described previously (20). Briefly, fragments of spleen 
were embedded in Tissue-Tek OCT (Miles Laboratories), snap-frozen in pre-chilled 
methyl-butane, and stored at –80° C. Cryostat sections (8 µm) of spleen were fixed in 
4% paraformaldehyde/PBS and blocked with 10% normal goat serum and the avidin-
biotin blocking kit (Vector Laboratories). Tissue sections were incubated with the 
following reagents (Ab were obtained from BD Pharmingen, unless specified): 1) 
biotin-anti-MOMA-1 mAb (Bachem) followed by Cy3-streptavidin (Jackson 
ImmunoResearch Laboratories) or 2) anti-CD11c mAb plus Cy3-anti-hamster IgG in 
combination with either biotin-CD3 mAb or biotin-Gr-1 mAb followed by Cy5-




Statistical analysis was performed using Prism 4 software (GraphPad software) and 





A rare population of CD11c+Gr-1+ cells in the peritoneal cavity is preferentially 
targeted following i.p. infection with tachyzoites 
To elucidate cell types parasitized by Toxoplasma during early infection, C57BL/6 
mice were infected i.p. with RH-YFP, a genetically engineered parasite strain 
expressing tandem copies of the gene encoding yellow fluorescence protein, and the 
peritoneal exudate cells were analyzed by flow cytometry 3 days later. As expected for 
Toxoplasma, a parasite known for its ability to promiscuously infect a diverse range of 
cell types, most cells in the peritoneal cavity were parasitized at this time point, 
including macrophages (F4/80+), neutrophils (Gr-1+), DCs (CD11c+), and B cells 
(B220+) (Fig. 2.1A). Nevertheless, while 50% of macrophages, neutrophils, and DCs 
harbored parasites, B lymphocytes and T lymphocytes were considerably more 
resistant to infection. In each case only a minority of cells were infected (20% and 5%  
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Figure 2.1. CD11c+Gr-1+ cells in the peritoneal cavity are highly susceptible to 
infection with T. gondii. A, Mice were infected i.p. with RH-YFP tachyzoites, and 
peritoneal exudate cells were harvested 3 days postinfection for phenotypic analysis 
and assessment of infection levels by flow cytometry. B, Costaining for CD11c and 
Gr-1 reveals a small population of CD11c+Gr-1+ cells in the peritoneal cavity 3 days 
postinfection. C, Examination of parasite levels in the CD11c+Gr-1+population reveals 
that these cells are highly susceptible to infection (black line histogram) compared 
with CD11c+Gr-1–cells (shaded histogram). The numbers indicate the percent of cells 




for B220+ and CD3+ lymphocytes, respectively). There are several subsets of DCs, 
including some that coexpress CD11c and Gr-1. A small population of the CD11c+ Gr-
1+ cells (<1%) was detected in the peritoneal cavity 72 h after infection (Fig. 2.1B). 
These cells were remarkable inasmuch as over 80% were positive for parasites (Fig. 
2.1C). 
 
The major population of infected cells in the spleen predominantly expresses CD11c 
and Gr-1 
We next examined infection in the spleen, an organ targeted by the parasite during 
acute infection (2, 6). Splenocytes were obtained from mice infected 4 days before by 
i.p. administration of RH-YFP tachyzoites. At this time point, 5–6% of 
total splenocytes were positive for T. gondii (Fig. 2.2A). Gating on the infected 
population, we found that the majority ( 70%) coexpressed CD11c and Gr-1 (Fig. 
2.2B). We also found that 20% of infected cells possessed a CD11c–Gr-1+ phenotype. 
This population is likely to be neutrophils, but it is also possible that some are Gr-
1+ inflammatory monocytes described by Sibley and colleagues (21, 22). We also 
determined the proportion of total splenic CD11c+Gr-1+ cells that were infected 
with T. gondii. As shown in Fig. 2.2C, 60% of this population harbored intracellular 
parasites. 
 
We wanted to investigate the phenotype of the CD11c+Gr-1+ population in more detail 
(Fig. 2.2D, upper panels). The cells expressed MHC class II, B220, CD11b, CD80/86, 
and PDCA-1. This profile, in particular expression of PDCA-1, Gr-1, and B220, was 
suggestive of a pDC-related population, although they are atypical in that they express  
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Figure 2.2. CD11c+Gr-1+ cells are the predominant population of infected cells in 
the spleen, and exhibit phenotypic characteristics of both plasmacytoid and 
myeloid dendritic cells. A, Splenocytes were harvested from mice 4 days 
postinfection and analyzed by flow cytometry for RH-YFP tachyzoites. B, CD11c and 
Gr-1 expression on YFP-positive cells. C, YFP expression in the total CD11c+Gr-
1+ population in the spleen. The numbers indicate the percent of cells falling within 
the indicated gates (A and C) or quadrants (B). D, Phenotypic analysis of infected 
CD11c+Gr-1+ (upper panels) and CD11c+Gr-1– cells (lower panels) shown in B. The 
solid lines represent each respective marker and the shaded histograms indicate 




CD11b and higher than expected levels of CD11c (23, 24, 25, 26). We also examined 
the phenotype of the CD11c–Gr-1+ population (Fig. 2.2D, lower panels). These cells  
expressed high  levels of CD11b, a molecule expressed by neutrophils. 
Interestingly, the cells were also positive for MHC class II and CD80. 
 
We examined the appearance of Gr-1+ parasite-infected cells in the spleen by 
fluorescence microscopy (Fig. 2.3). The vast majority of infected Gr-1+ cells were 
clearly distinct from the neutrophil population, because they possessed abundant 
cytoplasm and non-polymorphic nuclei. However, we were also able to detect some 
infected neutrophils, consistent with our data showing a population of infected CD11c–
Gr-1+ cells (Figs. 2.2B and 2.3C). 
 
Next, we used immunofluorescence staining of frozen tissue sections to localize 
infected cells in situ. In spleens of day 4-infected mice, parasites were mainly present 
in phagocytes of the marginal zone, red pulp, and to a lesser extent in cells of the 
lymphoid follicles (Fig. 2.4). Within the splenic follicles, T cell areas also contained 
CD11c+ DCs infected with T. gondii (Fig. 2.5, A and B). In Fig. 2.5, C and D, we used 




                                       
Figure 2.3. Morphology of Toxoplasma infected cells in the spleen. Mice were 
infected with RH-YFP tachyzoites (green), then 4 days later splenocytes were isolated 
and stained for Gr-1 (red) and DNA (DAPI, blue). Most infected cells exhibited a 
round or bean-shaped nucleus consistent with monocyte/macrophage/DC (A–C) and 
abundant cytoplasm, in which multiple parasites were found. Lesser numbers of 
infected polymorphonuclear leukocytes were also observed (C, arrow). The 








                   
Figure 2.4. Infected cells are located primarily in the marginal zone of the spleen. 
Spleens were obtained from mice 4 days postinfection and immunofluorescence on 
frozen sections was performed. Staining for metallophilic macrophages (MOMA-1, 
red) delineates the edge of the marginal zone (MZ), revealing concentration of 
infected cells (yellow) in this area (arrowheads), with a small number of infected cells 
(arrows) in the lymphoid follicle (F). The inset shows at high magnification a MOMA-
1+ cell with intracellular parasites. Blue, DAPI stained nuclei. Original 










                  
Figure 2.5. Infected cells in the T cell areas of the spleen coexpress CD11c and 
Gr-1. Mice were infected with RH-YFP tachyzoites and 4 days later spleens were 
collected for immunohistochemical staining. A, Four-color immunofluorescence 
staining of frozen sections shows CD11c+ cells (red) infected with RH-YFP 
(yellow).B, In the same section, staining for CD3 (pink) reveals T cells surrounding 
infected CD11c+ cells. Staining for CD11c (C) and Gr-1 (D) shows that most infected 
cells (arrows) coexpress CD11c (red) and Gr-1 (pink). Insets in C and D shows an 
expanded view of infected CD11c+Gr-1+ cells. Original magnification x400 (Aand B) 







CD11c+Gr-1+ cells migrate from the peritoneal cavity to the spleen 
Because we found that CD11c+Gr-1+ cells were highly susceptible to infection in the 
peritoneal cavity, we hypothesized that these cells may be migrating from the 
inoculation  site to the   spleen. To determine whether  this  was  the  case, we  infected 
congenic B6.SJL mice (CD45.1) with i.p. injected RH-YFP tachyzoites. Two days 
later we harvested the peritoneal exudate cells from the B6.SJL mice and transferred 
them by i.p. injection into CD45.2 congenic C57BL/6 mice infected i.p. 2 days before 
with RH-YFP tachyzoites. Spleen and peritoneal exudate cells were harvested 48 h 
after transfer. We found a small number of transferred cells, which were primarily 
noninfected, remaining in the peritoneal cavity at this time (data not shown). As 
expected, in the spleen there was background staining for CD45.1+ cells in 
nontransferred animals (Fig. 2.6A). However, we found adoptively transferred parasite-
infected CD45.1+ cells mobilized to the spleen in the CD45.2 congenic hosts (Fig. 
2.6B), and as predicted, these migrating cells coexpressed Gr-1 and CD11c (Fig. 
2.6C). We transferred cells from CD45.1+ mice infected with YFP-RH into CD45.2 
animals infected with nonfluorescent RH tachyzoites (Fig. 2.6D). As shown in 
the figure, we detected the appearance of YFP-RH infected, CD45.1+ cells in the 
spleen. As expected, these cells also expressed Gr-1 and CD11c (data not shown). 
Also evident in Fig. 2.6D, most of the YFP+ cells were derived from recipient mice, 
because they do not express CD45.1. The majority of these cells are positive for Gr-1 
and CD11c (data not shown), and it seems likely that they originate from host pDC 
infected in the peritoneal cavity by RH-YFP. We cannot be sure what accounts for the 
low percentage of CD45.1+ cells that traffic to the spleen in these situations. However, 
we suspect that the cells are negatively affected by the recovery and transfer protocol, 
and that many subsequently die after transfer. Regardless, from these data we conclude  
58 
                  
Figure 2.6. Infected CD11c+Gr-1+ cells migrate from the peritoneal cavity to the 
spleen. Peritoneal exudate cells from B6.SJL CD45.1 congenic mice were isolated 2 
days after i.p. inoculation with RH-YFP tachyzoites. The exudate cells were then 
adoptively transferred i.p. into congenic C57BL/6 CD45.2 host mice infected 2 days 
earlier with RH-YFP tachyzoites. Two days later splenocytes were harvested from the 
host mice and three-color staining for CD45.1, CD11c, and Gr-1 was conducted. A, 
splenocytes from a control day 4-infected C57BL/6 mouse that received no congenic 
peritoneal exudate cells, showing background staining for CD45.2. B, splenocytes 
from a day 4-infected C57BL/6 mouse adoptively transferred with CD45.2-positive 
peritoneal exudate cells. C, CD11c and Gr-1 expression of infected CD45.2+ cells in 
the spleen. The numbers indicate the percentage of cells falling within the indicated 
rectangles (A and B) and quadrants (C). The graphs show results from one 
representative mouse. In a group of four mice, the percentage of CD45.1+ cells after 
transfer was 0.14 ± 0.03. In D, CD45.1+peritoneal exudate cells from mice infected 
with RH-YFP parasites were transferred into CD45.2+ mice infected with 
nonfluorescent parasites. Spleen cells were recovered as above and CD45.1 expression 
was examined on YFP+ cells. The numbers in each graph indicate the percent of cells 
falling within the indicated quadrants or gates. 
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that infected CD11c+Gr-1+ cells are capable of migrating from the peritoneal cavity to 
the spleen over the course of infection. 
 
 
CCR2 is partially involved in recruitment of CD11c+Gr-1+ to the spleen 
The chemokine receptor CCR2 is involved in recruitment of inflammatory myeloid 
cells and DCs during several infections, including Toxoplasma and Listeria 
monocytogenes (10, 22). Therefore, we sought to determine whether CCR2 might play 
a role in recruitment of CD11c+Gr-1+ cells during infection. Accordingly, CCR2 
knockout mice were infected in parallel with wild-type controls and CD11c+Gr-
1+ splenocytes were analyzed 4 days postinfection. We found a major reduction in the 
number of CD11c+Gr-1+ cells in the spleens of infected mice in the absence of CCR2 
signaling (Fig. 2.7A). Nevertheless, recruitment of CD11c+Gr-1+ DCs to the spleen 
was not completely dependent upon CCR2 because there was a low, but significant 
increase in the number of these cells comparing noninfected with infected CCR2–/–
 mice. We also examined the influence of CCR5, another chemokine receptor 
implicated in resistance to T. gondii (27, 28, 29), on mobilization of CD11c+Gr-1+cells 
to the spleen during infection. In this case, absence of CCR5 had no impact on the 
migration of CD11c+Gr-1+ cells to the spleen following T. gondii infection (Fig. 2.7B). 
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Figure 2.7. CCR2 is partially involved in recruitment of CD11c+Gr-1+ cells to the 
spleen during infection. Wild-type and chemokine receptor knockout mice were 
infected with RH-YFP tachyzoites, and recruitment of CD11c+Gr-1+ cells to the spleen 
was assessed by flow cytometry. Recruitment of CD11c+Gr-1+ cells was defective in 
CCR2 knockout mice relative to wild-type controls (A), but unaffected in CCR5 
knockout mice (B). Data shown are pooled from three experiments, with two mice per 







Toxoplasma-infected CD11c+Gr-1+ DCs are refractory to TLR-induced IL-12p40 
production 
Splenic CD8 + DCs are a well-characterized source of IL-12 after i.v. injection 
of Toxoplasma lysate Ag (14). This activity is largely due to parasite profilin-TLR11 
interactions (15). However, our previous data has shown that Toxoplasma-infected 
macrophages  are suppressed in their ability to produce proinflammatory 
cytokines such as IL-12 when subjected to TLR stimulation (30). Similar findings 
have been reported by others using mouse bone marrow-derived DCs (17). Therefore, 
we sought to determine whether the CD11c+Gr-1+ DCs targeted for infection by T. 
gondii were stimulated to produce IL-12, or whether the parasite actively suppressed 
the cytokine. 
 
To discriminate between induction vs suppression of IL-12, splenic DCs from day 4-
infected mice were enriched using pan-DC immunomagnetic beads. In this 
population, 14% of the cells coexpressed CD11c and Gr-1 (Fig. 2.8A). The enriched 
DC population was cultured for 24 h in the presence of medium alone or with TLR 
ligands. Because the phenotype of the CD11c+Gr-1+ cells displayed characteristics of 
both pDC and conventional DC, and because these DC populations express distinct 
TLR ligands, we used a combination of TLR9 and TLR4 ligands (CpG and LPS, 
respectively) for stimulation. We then examined IL-12 p40 expression in infected and 
noninfected CD11c+Gr-1+ DCs. As shown in Fig. 8B, 9% of noninfected CD11c+Gr-
1+ cells produced IL-12 without further in vitro stimulation. After stimulation with 
TLR ligands, almost 40% of noninfected CD11c+Gr-1+ DCs expressed IL-12 (Fig. 
2.8C). In marked contrast to these results, only 2% of infected CD11c+Gr-1+ stained  
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Figure 2.8. IL-12 production is defective in CD11c+Gr-1+ cells infected with T. 
gondii. Splenocytes were harvested 4 days postinfection with RH-YFP tachyzoites and 
enriched for CD11c+ cells using magnetic beads. A, CD11c and Gr-1 expression levels 
in the enriched DC population. The number indicates the percent of cells in the 
indicated rectangle. Enriched cells were cultured 24 h in medium alone, or medium 
with CpG oligodinucleotide (1 µg/ml) and LPS (100 ng/ml). The cells were stained for 
intracellular IL-12p40 and surface Gr-1 and CD11c. B, IL-12 expression by 
noninfected CD11c+Gr-1+ cells cultured in medium alone. C, IL-12 expression by 
parasite-negative CD11c+Gr-1+ cells after in vitro stimulation with LPS + CpG. D, IL-
12p40 expression by YFP+ CD11c+Gr-1+ cells with no in vitro stimulation. E, 
Expression of IL-12p40 in infected CD11c+Gr-1+ cells after TLR ligand-stimulation. 
In B–D, the numbers indicate the percent of cells falling within the indicated 




positive for IL-12 during culture in medium (Fig. 2.8D), and with the addition of LPS 
and CpG, the percentage increased to only 14% (Fig. 2.8E). We conclude from these 
data that Toxoplasma targets CD11c+Gr-1+ cells for infection, and the parasite 
suppresses IL-12 production once inside the cells. 
 
Discussion 
The results of this study show that inoculation of mice with the tachyzoite stage of T. 
gondii leads to preferential infection of Gr-1-expressing DCs. CCR2 is involved in the 
migration of these cells from the peritoneal cavity to the marginal zone of the spleen, 
where they express markers associated with pDC. Infection with T. gondii suppresses 
the capacity of these cells to produce the proinflammatory cytokine IL-12 upon ex 
vivo stimulation with ligands for TLR4 and TLR9, while noninfected cells retain their 
ability to synthesize IL-12. Recently, inflammatory macrophages have been implicated 
in the early anti-microbial response to Toxoplasma. Those cells resemble the pDC-like 
population identified here in that they express Gr-1 and they display CCR2-
dependent recruitment (22). However, based upon expression of PDCA-1, CD11c, and 
B220, it is most likely that the two populations are distinct, and that the cells reported 
here are related to cells of the pDC lineage. 
pDCs are differentiated effector cells specialized for production of anti-viral type I 
IFN (25). However, they possess the unusual property of being able to differentiate 
into conventional DCs that activate naive T cells and instruct adaptive immunity 
through production of mediators such as IL-12 (31). Differentiation can be induced by 
cytokines such as IL-3, and also microbial stimuli including bacteria and viruses 
(26, 32). Accompanying pDC differentiation into DCs, the cells acquire dendritic 
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morphology and up-regulate CD11c, MHC class II, and costimulatory 
molecules. However, there are likely to be functional differences between pDC-
derived DCs and conventional DCs insofar as activation of naive T cells by pDC-
derived DCs leads to generation of regulatory T cells in several cases (33, 34). pDCs 
may also differ from conventional DCs in terms of Ag uptake and processing (35, 36). 
Although the cells targeted for infection express markers associated with pDCs, 
namely PDCA-1, Gr-1 and B220, they are nevertheless atypical in that they also 
express the monocyte lineage marker CD11b. A potential explanation for this unique 
phenotype may relate to differentiation of pDC into DC under 
inflammatory conditions. During infection with lymphocytic choriomeningitis virus, 
bone marrow-derived pDCs down-regulate B220 and Gr-1 and up-regulate CD11b, 
dependent upon type I IFN (37). Interestingly, this was found to be a two-step process, 
in which CD11b was first up-regulated, followed by down-regulation of B220. 
After this transformation, the cells were also newly capable of producing IL-12 in 
response to TLR4 activation, indicating functional as well as phenotypic conversion. 
In this regard, it is of interest that Toxoplasma was recently shown to stimulate type I 
IFN secretion by pDCs (16). We hypothesize that T. gondii infection stimulates an 
intermediate stage of pDC to conventional DC conversion, associated with 
coexpression of pDC and myeloid DC markers. Whether this is a stable phenotype 
associated with infection, or is a transitory state on the way to a conventional DC 
phenotype remains to be determined. 
In addition to type I IFN secretion, pDCs also produce IL-12 upon stimulation with T. 
gondii or soluble tachyzoite Ag, and they are also capable of presenting Ag during 
infection (16). This observation suggests a role for pDCs in the induction of the 
adaptive immune response to Toxoplasma. However, although we did not examine Ag 
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presenting capability, our work argues that T. gondii infection suppresses pDC IL-12 
production. In this regard, pDCs cultured in vitro from the bone marrow were used in 
the experiments showing IL-12 production in response to T. gondii, whereas the pDCs 
identified in the present study were enriched from the spleens of infected animals. 
Therefore, it is possible that the cells identified here are functionally distinct from 
pDCs generated in vitro. Additionally, we used flow cytometry to separate splenic 
pDCs into infected and noninfected populations. Although the infected pDC 
population was suppressed in IL-12 production, we found substantial IL-12 production 
by the noninfected pDC population. Thus, we also found that pDCs present during T. 
gondii infection are a source of IL-12. However, our study demonstrates that when 
pDCs are directly parasitized, their ability to produce IL-12 is suppressed. 
We, and others, previously reported that T. gondii inhibits TLR-induced IL-12 
production by bone marrow-derived macrophages and DCs (17, 38). The present study 
is significant because it is the first to demonstrate the suppression phenomenon in 
cells parasitized during in vivo infection. Inhibition of TLR signaling may be a 
consequence of the need to avoid activation by the parasite’s own TLR ligands 
(15, 39). The mechanisms of suppression are not clear, although the parasite has 
blocking effects on both NF B and MAPK signaling pathways (30, 40, 41, 42). More 
recently, IL-10-independent STAT 3 activation driven by injection of Toxoplasma 
rhoptry protein kinases into the host cell cytosol has been implicated in IL-12 
inhibition (43, 44). 
A key question is why Toxoplasma would target pDCs for preferential infection. As 
immune effectors, pDCs have two major functions, which are to produce large 
quantities of anti-viral type I IFN and to present Ag (25). pDCs are not known to 
possess strong microbicidal activity, unlike macrophages and other myeloid DC 
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populations. Therefore, pDCs may offer a more hospitable environment for the 
invading parasite relative to other cell types. Furthermore, activated DCs are highly 
motile, and are sensitive to chemokine-mediated recruitment to lymphoid 
organs draining the site of infection or inflammation. In this regard, it has long been 
known that Toxoplasma infection initially spreads through the lymphatics, and 
lymphoid organs become rapidly parasitized during infection (45). Therefore, pDCs 
may provide the parasite with a safe vehicle for dissemination during early infection. 
It is an unexpected finding that pDCs play a role in the immune response 
to Toxoplasma. Although we used a virulent parasite strain that leads to 100% lethality 
in this study, preliminary data (not shown) suggests that low virulence strains 
capable of establishing long-term infection also preferentially parasitize  pDCs. Other 
protozoa, including Plasmodium and Leishmania spp. are known to display complex 
interactions with DCs (46, 47). Whether these pathogens also target the pDC 
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Toxoplasma gondii is an obligate intracellular parasite that infects a wide range of 
warm-blooded hosts, and can lead to severe disease in immunocompromised 
populations. In North America and Europe, three clonal lineages comprise the 
majority of T. gondii strains, and severity of disease and host-pathogen interactions 
vary among these strains. Recently, I demonstrated that cells with phenotypic 
characteristics of plasmacytoid dendritic cells (pDC) are hypersusceptible to invasion 
by Type I tachyzoites, and that these parasites use pDCs as Trojan horses for 
dissemination to the spleen during early acute infection. In this study, I used 
representatives of each strain type in an intraperitoneal model to determine whether 
this use of dendritic cells was restricted to Type I parasites, or whether it was a general 
characteristic of T. gondii infection regardless of strain type. I found that tachyzoites 
of Types I and II were more likely to infect CD11c+Gr-1+ cells in the spleen than Type 
III tachyzoites, and that Types II and III strains induced a greater recruitment of 
conventional DC at the infection site compared with Type I. Therefore, I conclude that 
different T. gondii strains contribute to variations in recruitment and invasion of cells 
during acute infection.  
 
Introduction  
Toxoplasma gondii is an intracellular protozoan parasite of the phylum Apicomplexa, 
which infects approximately 9% of people in the United States (1). The parasite 
completes its life cycle in members of the cat family (2), but can persist in a chronic 
state in most birds and mammals (3-4). Infection of individuals with compromised 
immunity, such as AIDS patients, as well as transplacental infection of a fetus, can 
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lead to serious clinical outcomes (5-6). Therefore, T. gondii is an important 
opportunistic pathogen and the subject of extensive research.  
 
Three clonal lineages comprise the majority of T. gondii strains in North America and 
Europe (7). Infection with different strains can lead to different clinical outcomes, as 
Type II is the most common strain found in infections in the United States, but Type I 
is the strain most likely to be associated with severe disease such as ocular 
toxoplasmosis (7-9). Several features of parasite biology and host-parasite interaction 
vary depending on the strain type. Type I is the most virulent strain in mice, and it has 
been hypothesized that this high virulence is due to a number of factors, including 
heightened capacity for crossing endothelial barriers, enhanced migration ability and a 
quicker replication rate compared to Types II and III (10-11). This, in turn, may lead 
to greater parasite burden, increased production of Th1 cytokines, and 
immunopathology (12-13). The rhoptry kinase ROP18, which exhibits allelic variation 
between strains, has been identified as the virulence factor responsible for this 
enhanced growth (14).   
 
Strain differences can also be observed in the induction and suppression of 
proinflammatory cytokines by T. gondii. Type I and Type II differ in how they induce 
IL-12 production, in that Type I acts solely through a MyD88-independent 
mechanism, while Type II uses MyD88-dependent as well as independent pathways 
(15). This is reflected by the higher levels of IL-12 elicited by Type II infection in 
vitro (16). Additionally, Types I and III, but not Type II, activate signal transducer and 
activator of transcription 3 (STAT3) when they invade cells, diminishing 
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proinflammatory cytokine production (16). The virulence factor ROP16 has been 
implicated in strain-specific activation of STAT3 (17). Finally, differences have been 
observed in cell recruitment at the site of infection after intraperitoneal inoculation 
with Types I and II parasites, in that the cells recruited by Type II parasites are 
primarily Gr-1+ monocytes, whereas more neutrophils are recruited by Type I 
infection (18). It has been suggested that this difference is largely responsible for the 
difference in parasite control between Types I and II during acute infection (18).  
 
Recently, dendritic cells have been proposed as Trojan horses during T. gondii 
infection. Parasites in the mesenteric lymph nodes and blood after intragastric 
inoculation are associated with CD11c+ and CD11b+ cells, respectively, and CD11c+ 
and CD11b+ cells in the blood of infected mice home to the brain within 7 days (19).  
In vitro studies demonstrated that Toxoplasma infects immature dendritic cells more 
readily than mature DC, and is capable of inhibiting their activation, as measured by a 
suppressed ability to produce IL-12 and TNF-α and activate naïve CD4+ T 
lymphocytes (20). Furthermore, studies on dendritic cell motility have demonstrated 
that infection with T. gondii enhances migration of DCs in vitro by suppressing 
upregulation of the adhesion molecule ICAM-1. This hypermotility phenotype leads to 
more efficient dissemination to lymphoid organs in vivo compared to that of DCs 
activated by lipopolysaccharide, as well as more effective dissemination of tachyzoites 
compared to infection with parasites alone (21). Finally, one study showed that 
although all strain types induce hypermotility in DC, Types II and III induce this 
phenotype more strongly than does Type I (22), suggesting that the parasitic utilization 
of dendritic cells as vehicles for dissemination may be heightened based on parasite 
strain type.  
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In this study, I used an intraperitoneal model of infection to compare the three major 
parasite strains in terms of which cells they targeted for infection. My previous work 
had demonstrated that cells with a plasmacytoid DC phenotype were highly 
susceptible to parasitization and migrated from the infection site to the spleen, 
comprising the majority of infected cells at that site at four days post-infection (23). 
Here I find that, at day 5 post-infection in the spleen, infection has spread to other cell 
types in Type I-infected mice, but there are no significant strain-related differences 
between infection of cell types. I observe differences in the composition of the 
infected population in the peritoneal cavity at day 3 post-infection, as a greater 
percentage of these cells are CD11c+ DCs in Type II and Type III infections, whereas 
the infected cells in the Type I peritoneal cavity are dominated by Gr-1+ cells. I 
conclude that strain type contributes to variations in infection of certain cell types at 




Materials and Methods  
Mice. C57BL/6 mice 6-8 weeks of age were purchased from Taconic Farms and 
housed in the Cornell University College of Veterinary Medicine transgenic mouse 
core facility, which is accredited by the American Association for Accreditation of 
Laboratory Animal Care.  
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Parasites and Infections. RH (Type I), PTG (Type II) and VEG (Type III) tachyzoites 
were purchased from the American Type Tissue Collection and maintained in human 
foreskin fibroblasts in DMEM (Mediatech) supplemented with 1% bovine growth 
serum (Hyclone), 100 U/mL penicillin and 100 U/mL streptomycin (Invitrogen Life 
Technologies). Mice were infected with 106 tachyzoites (TZ) intraperitoneally.  
 
Flow Cytometry. At days 3 and 5, infected mice were sacrificed, spleens were 
harvested, and peritoneal exudate cells (PEC) were collected by peritoneal lavage. 
Splenocytes and peritoneal exudate cells were filtered through 70 µm filters, and 
incubated on ice for 15 min with 10% normal mouse serum in FACS buffer (1% BSA 
and 0.05% sodium azide in PBS). Cells were then incubated for 30 minutes on ice with 
fluorochrome-conjugated antibodies (BD Biosciences, BioLegend, Argene, 
eBioscience), washed and fixed in 3% paraformaldehyde. Permeabilization was 
performed with 0.075% saponin in phosphate-buffered saline, and permeabilized cells 
were incubated on ice for 30 minutes with antibody to parasite surface marker p30 and 
thoroughly washed. Cells were then read on a Becton-Dickinson FACSCalibur, and 
data was analyzed using FlowJo software (Treestar).  
 
Results 
Cell recruitment to the peritoneal cavity varies among strain types. Mice were 
sacrificed at 3 days post-infection with a high dose of Type I, II or III tachyzoites, and 
peritoneal exudate cells (PEC) were collected for staining of surface markers and 
parasites using an antibody to the T. gondii surface antigen p30, and analysis by flow 
cytometry. Slight, but reproducible differences were observed in the recruitment of 
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different cell populations to the peritoneal cavity (Figure 3.1, Table 3.1). Infection 
with Types II and III led to greater numbers of CD11c+ dendritic cells in the infected 
population, as DCs comprised roughly 50% of the infected cells after inoculation with 
these strains. By contrast, DC only accounted for a third of the infected cells in Type 
I-infected PEC, whereas CD11c-Gr-1+ cells dominated the infected population. The 
CD11c-Gr-1+ group was a mixed population, with the majority of cells staining with 
the Ly6G-specific antibody 1A8 (neutrophils), and the rest negative for this marker 
(likely inflammatory monocytes). Additionally, Type I parasites induced nearly twice 
the percentage of 1A8-staining neutrophils compared with Types II and III, and Types 
II and III induced twice as many CD8+ cells.  
  
Infected cells in the peritoneal cavity are mostly myeloid DC, inflammatory DC, and 
neutrophils. Day 3 peritoneal exudate cells from mice infected with the three strains of  
parasite were gated on parasite-positive cells and analyzed for surface markers (Table 
3.1, Figure 3.2). With all three strains, infected cells were composed of three major 
populations, CD11c+Gr-1- cells, CD11c+Gr-1+ cells, and CD11c-Gr-1+ cells. PEC from 
Type I-infected mice showed a striking lack of CD11c+Gr-1- cells in comparison to 
Types II and III, with Gr-1- DC comprising only 9.13% of the infected cells, compared 
to 21.4% and 21.3%. All three populations expressed CD11b, indicating myeloid 
origin, but only the CD11c-Gr-1+ cells stained with the neutrophil-specific antibody 
1A8. These phenotypes are consistent with myeloid-derived dendritic cells, 















































                                                                                                                                                                       
Figure 3.1. Cell recruitment and parasitization of cell populations      
varies on infection with different strains of T.gondii. Day 3 peritoneal  
exudate cells were harvested and stained for surface markers (y-axis) and  
tachyzoites (x-axis). PEC Type I-infected mice were composed of greater  
numbers of 1A8+ cells, while PEC of Types II and III had a larger   
CD11c+ population. A higher percentage of Type I parasites were found  
in Gr-1+ cells, and a higher percentage of Type II parasitized DC. These  
differences were statistically significant by a two-tailed Student’s t-test,  








Table 3.1. Strain type influences representation of different cell types among 
infected cells in the peritoneal cavity. Day 3 post-infection, peritoneal exudate cells 
(PEC) were harvested and stained for surface markers and parasite. PEC from Type II 
and III-infected mice are comprised of greater numbers of dendritic cells, and DC are 
the major infected population as well, whereas Gr-1 cells are the greater infected 
population with Type I. However, the differences between percentages of DC and 
neutrophils recruited are not statistically significant by two-tailed Student’s t-test, as 
the p-value for total percentage of PEC belonging to the CD11c+ population is 0.33 
between Types I and II, and 0.17 for the total percentage of infected PEC belonging to 
the Gr-1+ population. The preference of Type II for infecting DC is statistically 
significant, however, with a p-value of 0.043 when compared to Type I, as is the 
preference of Type I for Gr-1+ cells, with a p-value of 0.01 when compared to Type II. 
Data shown are the results of three independent experiments.  
 
Day 3 PEC                    Total Cell %                          % of Infected Cells 
Infection CD11c+   Gr-1+ CD11c+





Type I (RH)      
  1  33.2 73.1 6.67 64.4 23.3 
  2 14.13 59.6 4.66 61.2 16.6 
  3    29.9 60.0 9.13 56.5 26.1 
Type II (PTG)      
   1 45.44     49.1    30.1    33.1    24.3 
   2    24.23  21.79 10.9 34.2 33.2 
   3     45.8 60.3 21.4    40 26.1 
Type III (VEG)      
   1     nd    nd nd nd nd 
   2 40.64 35.42 21.2 33.7 27.9 
   3       40.68 49.58 21.3 39.6 27.0 
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Infection in the spleen does not exhibit significant differences between strain types. 
Splenocytes from infected mice were harvested 5 days after inoculation, and analyzed 
for tachyzoites and surface markers (Figure 3.3). Infection rate of spleens with Types 
II and III was much lower than with Type I, as spleen cells from the first two strains 
were infected at a rate of 0.38% and 0.23% respectively, while Type I infected at a 
rate of 3.75%. Association of parasites with CD11c+Gr-1+ cells was much weaker at 
day 5 than on day 4, according to my previous observations, but Type I and II 
tachyzoites were more strongly associated with this population than Type III; 
however, this result was not statistically significant. Additionally, Type III tachyzoites 
infected a relatively large population of CD11c-Gr-1- cells in two out of three 
experiments, in contrast to Types I and II (Table 3.2). This double-negative population 
consists of 80% CD11b- cells (data not shown), and this phenotype suggests that these 
cells may be lymphocytes or Gr-1- macrophages. However, this result was not 
statistically significant, either. Therefore, these results suggest that variations in 
parasite invasion of different cell populations, or utilization of Gr-1-expressing 
dendritic cells as vehicles for dissemination, do not exist between strain types.  
 
Discussion 
In this study, I have shown that intraperitoneal inoculation with representative strains 
of the three major clonal lineages of T. gondii leads to variations in cell recruitment at 
the infection site and parasitization of cell populations in the peritoneal cavity. While 
Type I infection induces a greater percentage of 1A8+ neutrophils in the peritoneal 
cavity  at  three days  after  infection,  Types II  and  III lead to  a  higher,  though  not  
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Figure 3.2. Infected cells in the peritoneal cavity on day 3 belong to  
three major groups: CD11c+ Gr-1- DC, CD11c-Gr-1+ neutrophils, and  
CD11c+Gr-1+ cells. Peritoneal exudate cells were collected on day 3 post- 
infection and stained for surface markers and intracellular parasites (p30).  
Gating on parasites revealed three major groups of infected cells,  
CD11c+Gr-1- cells, CD11c-Gr-1+ cells, and CD11c+Gr-1+ cells. Gating on  
the CD11c+Gr-1+ cells revealed that they were CD11b+ and 1A8- (black 
histogram = surface molecule, grey histogram = isotype control),  
suggesting monocyte-derived DC, while CD11c-Gr-1+ cells were CD11b+  
and 1A8+, indicating neutrophils.  
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Figure 3.3. Infection of splenic cells does not vary significantly  
between strain types. Five days post-infection, splenocytes were  
harvested and stained for tachyzoites (TZ) and surface markers. Cells  
were gated on presence of tachyzoites, then analyzed for CD11c and Gr-1  
expression. Variations in cell populations infected by different strain  
types were not statistically significant. (Grey histogram = isotype control,  




Table 3.2. Strain type does not influence infection of different cell types in the 
spleen. Splenocytes were harvested from mice infected ip with a high dose of 
tachyzoites on day 5 post-infection, and stained for surface markers and cytokines. In 
two out of the three experiments, Types I and II tachyzoites were more frequently 
found in Gr-1-expressing DC compared to Type III; however, a two-tailed Student’s t-
test determined that the p-value of the percentage of Gr-1+ DC in the infected 
population between RH and PTG was 0.75, and was 0.37 between RH and VEG. 
Therefore, these variations are not statistically significant.  
 
Spleen, day 5                                        % of Infected Cells 
Infection CD11c+Gr-1- CD11c-Gr-1+ CD11c+Gr-1+ CD11c-Gr-
1- 
     
Type I (RH)     
  Experiment 1  15.8 50.3 15.7 18.2 
  Experiment 2 15.5 45.3 20 19.2 
  Experiment 3 15.4 29.3 42 13.3 
 
Type II (PTG)     
   Experiment 1      15.4    38.5    7.69    38.5 
   Experiment 2      15.4 38.5 28.6 17.6 
   Experiment 3  8.13 42.2 30.4 19.3 
 
Type III (VEG)     
   Experiment 1      15.8 15.8 18.4 50 
   Experiment 2 7.27 41.8 12.7 37.3 
   Experiment 3      12.5 50 20.8 16.7 
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significantly higher, percentage of CD11c+ dendritic cells. Unsurprisingly, given the 
higher proportion of these cells in the total population, Type I tachyzoites infect 
neutrophils and Gr-1+ cells in general at a higher frequency than Types II and III, and 
Types II and III infect DC at a higher frequency than Type I. In the spleen on day 5 
post-infection, Type I tachyzoites are no longer as restricted to the CD11c+Gr-1+ 
population as they are on day 4. Type I and especially Type II parasites, however, are 
more closely associated with this population of cells than are Type III in two out of 
three experiments. Conversely, nearly 40% of Type III tachyzoites are associated with 
a CD11c-Gr-1- population, possibly lymphocytes or resident Gr-1- macrophages, that 
comprises less than one- fifth of the cells infected with Types I or II. However, the 
results from the spleen do not rise to the level of statistical significance, indicating that 
variations in splenic infection between strain types may simply be due to natural 
experimental variation.  
 
Previous studies examining the variations between infection with different 
Toxoplasma strains have identified differences in cell recruitment, DC motility, and 
manipulation of cell signaling for induction of cytokines (18, 21, 14). My work 
confirmed a previous observation that more neutrophils are recruited in response to 
Type I parasites than Type II after intraperitoneal inoculation (18), and expanded on 
this finding by showing that Type III parasites are similar to Type II in terms of which 
cells are recruited to the infection site. One major difference that Type I exhibits 
relative to Types II and III is growth rate (10), and this is evident in the relative 
percentages of cells infected by each of these strains on day 3 post-infection. Growth 
rate may also be responsible for the variation in which cell types are infected. My 
work recapitulated previous studies (18) showing that Type I is more frequently 
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associated with neutrophils at the peritoneal cavity compared to Types II and III, but 
also demonstrated that a higher proportion of infected cells belong to the DC 
population in Types II and III infection, and that there is a higher total percentage of 
peritoneal cells expressing CD11c as well. This difference may be due to strain-
specific variations in the induction of DC-attractant chemokines, or perhaps all strains 
induce recruitment of dendritic cells equivalently, but the higher growth rate of Type I 
leads to faster parasitization and lysis, prior to the day 3 timepoint.  
 
Previous studies have shown that infection with all strains of T. gondii increases 
motility in dendritic cells, preventing the upregulation of the adhesion molecule 
ICAM-1 and causing more rapid migration to the spleen and lymph nodes compared 
with LPS-activated DC (21). Out of all the strains, however, Type II induced this 
hypermotility most strongly (22). My work with Type I intraperitoneal infections 
identified a population of Gr-1+ dendritic cells that migrated to the spleen from the 
peritoneal cavity after infection with tachyzoites. At day 5 post-inoculation in the 
spleen, I found that Type I and II parasites were associated more strongly with 
CD11c+Gr-1+ cells than Type III parasites; however, this difference was reproduced 
only twice out of three experiments, and was not statistically significant. The lack of 
variation between strains in terms of dendritic cell migration to the spleen is 
surprising, given the strain-specific differences in dendritic cell motility described in 
other studies (22); nevertheless, the question of whether Types II and III use Gr-1-
expressing DC for dissemination in the same manner as Type I remains open.  
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Further work will be needed to determine whether the presence of a highly-infected 
splenic population of CD11c+Gr-1+ cells during Type II infection means that these 
cells are utilized by the parasite in the same fashion as they are by Type I. 
Nevertheless, the strain type of T. gondii clearly influences the cell populations 
infected in the peritoneal cavity, and these differences may point to strain-specific 
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CHARACTERIZATION OF EARLY CELL TARGETS OF T. GONDII  
















Toxoplasma gondii invades host cells in a promiscuous manner, and is capable of 
replication inside all nucleated cell types. In recent years, however, evidence has 
suggested that T. gondii uses specific cell populations such as dendritic cells and 
natural killer cells for enhanced dissemination throughout the host. In this study, I aim 
to elucidate the earliest cell populations targeted for invasion in the intestine and the 
intestinal lymphoid regions, to determine whether the preference for DC manifests at 
early stages after the natural route of infection. Surprisingly, I found that T. gondii 
infection is mostly in CD3+ cells in the mesenteric lymph nodes, and the largest 
population of infected cells in the Peyer’s patches are B220+, while infection in the 
lamina propria occurs in B220+CD11c- and Gr-1+CD11c- cells. Infection of MyD88-/- 
mice revealed a diminished recruitment of dendritic cells to both the mesenteric lymph 
nodes and Peyer’s patches, as well as increased infection rates among total cells, but 
the absence of this adaptor molecule did not appear to affect infection patterns. I 
conclude that dendritic cells are not the major targets of infection at these time points 
after oral inoculation in the intestine, but that further work will be needed to determine 
whether they are targeted at other times during infection.  
 
Introduction 
Toxoplasma gondii is a protozoan parasite that infects mammals and birds (1-2) 
through ingestion of environmentally-hardy oocysts, or tissue cysts in the muscle of 
prey animals (3). The cyst wall is dissolved in the stomach, releasing the slow-
growing form of the parasite, the bradyzoite, into the small intestine (4). Within 18 
hours, bradyzoites convert to the rapidly-dividing form, the tachyzoite, which 
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disseminates throughout the body and leads to chronic infection in the central nervous 
system and skeletal muscle (5). T. gondii is an obligate intracellular parasite, relying 
on the cells of its host for nutrients as well as for protection from extracellular 
immunity, and is capable of surviving and replicating inside any nucleated cell type 
(6-8). Some studies in vitro have shown preferential invasion of certain cell types, 
however, such as a marked preference for immature compared to mature DCs (9), and 
during in vitro infection of macrophages, some cells are invaded by large numbers of 
parasites while some remain entirely parasite-free (unpublished observations). This 
indicates that the parasite is perhaps capable of selective invasion, despite not being 
necessarily restricted to certain cells.  
 
Recent studies have addressed the question of whether T. gondii, like some other 
intracellular pathogens (10), utilizes specific cell types as Trojan horses for spreading 
to distant tissues. Natural killer cells have been implicated in in vitro studies as 
potential safe havens for T. gondii infection, as they are highly susceptible to infection 
after they lyse infected dendritic cells, and are resistant to killing by non-infected NK 
cells (11). Studies in macrophages have demonstrated Toxoplasma’s capability to 
suppress various immune-activating functions by innate immune cells, creating a more 
hospitable environment for the organism. In vitro studies have shown that T. gondii 
can downregulate surface molecules necessary for antigen-presentation, such as MHC 
Class II (12-13), as well as molecules involved in parasite killing, such as iNOS (14-
15). The parasite also interferes with apoptotic pathways via prevention of cytochrome 
c release and therefore disruption of the caspase cascade, as well as activation of the 
Gi-dependent phosphoinositide 3-kinase pathway and phosphorylation of protein 
kinase B (16-17). Additionally, intracellular T. gondii is capable of dampening the 
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proinflammatory cytokine response in macrophages by inhibiting chromatin 
remodeling and blocking translocation of NF-κB to the nucleus, as well as through 
activation of the signal transducer and activator of transcription 3 (STAT3) (18-20).  
 
Dendritic cells are also likely Trojan horse candidates during oral infection, as T. 
gondii has been shown to modify their behavior in several important ways. In vitro 
studies have shown that dendritic cells acquire a hypermotility phenotype when 
infected with live parasites, and when transferred to mice, arrive more swiftly to the 
spleen and the lymph nodes than do LPS-activated DC. Additionally, transfer of 
tachyzoite-infected DC leads to more rapid parasite dissemination to distant sites in 
the body than infection with parasites alone (21). Studies of in vivo infection by 
intragastric inoculation of cysts showed that blood CD11b+ and CD11c+ cells bearing 
parasites cross into the brain (22). Finally, in vivo work with the intraperitoneal model 
of infection has shown a distinct population of Gr-1-expressing DC as 
hypersusceptible to infection at the inoculation site. The infected Gr-1+ DC migrate to 
the spleen, where they are the majority of the infected population. These cells produce 
IL-12 upon TLR ligand stimulation, but are suppressed in this capability when 
parasitized (23).  
 
Using an oral model of inoculation with Type II cysts, I find that the infected cell 
population in the mesenteric lymph nodes appears to be dominated by CD3+ T 
lymphocytes, which would be expected if infection was nonpreferential as these are 
the dominant cell population in the lymph nodes. Similarly, the largest cell population 
in the Peyer’s patches, B220+ cells, are also the majority infected population, again 
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suggesting nonpreferential infection. In the lamina propria, however, the largest 
infected cell populations are B220+ and 1A8+ cells, the latter of which is striking 
because 1A8+ neutrophils only comprise about 1% of the total cell population. These 
results suggest that cells other than dendritic cells are the targets of infection at early 
timepoints in the intestinal lymphoid tissues and lamina propria. However, given the 
findings of Courret et al. regarding dendritic cell involvement in transport of 
tachyzoites to the brain (22), this should not rule out the possibility that dendritic cells 
are utilized as vehicles for dissemination at other points during oral infection.   
 
Materials and Methods 
Mice 
Female C57BL/6 mice 6-8 weeks in age were purchased from Taconic Farms 
(Hudson, NY). MyD88-/- mice on a C57BL/6 background were provided by Dr. E 
Perlman (Case Western Reserve University, Cleveland, OH) and originally generated 
by S. Akira (Osaka University, Osaka, Japan). We produced homozygous mice by 
crosses of heterozygotes, and genotype of the progeny was determined by RT-PCR 
using the following primers:  MyD88(forward) 5'-TGG-CAT-GCC-TCC-ATC-ATA-GTT-
AAC-C-3', (reverse) 5'-GTC-AGA-AAC-AAC-CAC-CAC-CAT-GC-3', and (neo) 5'-ATC-
GCC-TTC-TAT-CGC-CTT-CTT-GAC-G-3'.  
 
Parasites and Infections 
ME49 cysts were maintained by chronic infection in Swiss Webster mice (Harlan). 
Isolation of cysts was performed by removing the brain and homogenizing with the 
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plunger of a syringe and repeated passage through an 18-gauge needle. Brain 
homogenate was then mixed with 40% Percoll and underlaid with an equivalent 
amount of 80% Percoll, and centrifuged at 1600 RPM for 20 minutes to separate cysts, 
tissue and red blood cells. Cysts were counted and administered to mice by oral 
gavage. 
  
Isolation of Lamina Propria Cells 
Intestines were flushed with ice-cold PBS and sliced longitudinally, then minced with 
dissection scissors. Tissue pieces were incubated with PBS + dithiothreitol (Sigma) 
under rotation for 20 minutes at 37o C, vortexed, and supernatants containing 
epithelial layers were removed. This step was repeated twice. Remaining tissue was 
incubated for 20 minutes at 37o C with Liberase CI (0.2 mg/mL) and recombinant 
DNAse I (0.5 mg/mL) two times, or until all tissue had been digested. Supernatant was 
immediately centrifuged after each collection and the cell pellet was resuspended in 
serum-containing PBS. Cell viability was tested using Trypan blue.  
 
Flow Cytometry 
Mesenteric lymph nodes and Peyer’s patches were obtained from infected mice and 
digested with Liberase CI for 20 minutes (Roche). Cells were then blocked in a 96-
well plate with buffer (1% fetal calf serum in phosphate-buffered saline) and 10% 
normal mouse serum. Cells were then incubated with antibodies to surface markers 
(BD Biosciences, BioLegend, Argene, eBioscience) on ice for 30 minutes, washed and 
fixed in 3% paraformaldehyde. Permeabilization was performed with 0.075% saponin 
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in phosphate-buffered saline, and cells were then incubated with antibody to T. gondii 
surface antigen, p30, and washed before being analyzed on a FACSCalibur (Becton-
Dickinson), and the data was analyzed with FlowJo software (TreeStar). 
 
Immunofluorescence 
Intestines were removed from mice and flushed with PBS, then cut into small sections 
and embedded in OCT freezing medium (Miles Laboratories), and frozen on dry ice. 
Cryostat sections of 8µM thickness were fixed in acetone and stored at -80o C. Tissue 
sections were blocked using 2x casein and goat serum, then stained with mouse anti-
Toxoplasma gondii p30, rat anti-mouse CD3 and rat anti-mouse 1A8. Sections were 
washed twice in PBS, then stained with AlexaFluor 488 goat anti-mouse, and 
AlexaFluor 647 goat anti-rat. Slides were washed again and fixed in 4% 
paraformaldehyde, rinsed in water and mounted with ProLong Anti-fade with DAPI 
(Invitrogen). Stained sections were visualized on a Leica SP5 confocal microscope.  
 
 
Histology and Immunohistochemistry 
Intestines were removed from mice and flushed with PBS. They were then placed in 
10% formaldehyde overnight, and then cut and sent to the Histology Unit, Cornell 
University College of Veterinary Medicine (Ithaca, NY) for embedding in paraffin and 
staining for hematoxylin and eosin, as well as staining with rabbit anti-Toxoplasma 




Infection is promiscuous at day 3 post-infection in the mesenteric lymph nodes and 
Peyer’s patches. Three days after oral infection with 100 ME49 cysts, mesenteric 
lymph nodes and Peyer’s patches were isolated and stained for surface markers and 
parasites (Figure 4.1). In the mesenteric lymph nodes, the cell type most highly 
represented in the infected population was CD3+ T lymphocytes, accounting for 69% 
of infected cells, and T cells were also the largest population in the lymph nodes 
overall, at 57.3%. However, the proportion of infection in innate immune cells was 
higher due to their lower total frequency, particularly in CD11c+ cells. While CD3+ 
cells were infected at a rate of only 0.02%, the infection rate in CD11c+ cells was 
0.2%.  A similar situation was observed in the Peyer’s patches, in that B220+ cells 
were the largest total population, and also the largest population of infected cells, but 
other cell types were, proportionally, more heavily infected. Overall, though a 
preference may exist for innate immune cells, all cell types examined are infected at 
this time point.  
 
Infection is dominated by lymphocytes at days 5 and 7 post-infection. Five and seven 
days after oral inoculation, cells from mesenteric lymph nodes and Peyer’s patches 
were harvested for flow cytometric analysis of surface markers and parasites (Figure 
4.2). On day 5 in the mesenteric lymph nodes, CD3+ T lymphocytes were the primary 
infected  population,  comprising 61%  of  infected  cells,  followed by  B220+ cells  at 
33%. Cells expressing CD11b, Gr-1, CD11c and 1A8 were infected at a higher rate 
proportionally to their overall representation in the lymph nodes, however. While 






















































Figure 4.1. Infected cells are primarily T lymphocytes in the mesenteric lymph  
nodes on day 3 post-infection. Mice were infected with 100 cysts by oral gavage,  
and sacrificed three days post-infection. Mesenteric lymph nodes (MLN) and 
Peyer’s patches (PP) were removed and digested to a single-cell suspension, then    
stained for surface markers and intracellular parasites. One million cells were  
collected per sample. Infection in the mesenteric lymph nodes was mostly in the CD3+  
lymphocytes, whereas the infected population was evenly divided among the cell   
types in the Peyer’s patches (A). Infection rates per cell type (as defined by surface  
marker) are as follows: MLN B220: 0.009% CD3: 0.02% CD11c: 0.2% Gr-1: 0.04%  
CD11b: 0.09% 1A8: 1.8%  PP B220: 0.02% CD3: 0.05% CD11c: 0.4% Gr-1: 0.7%  
CD11b: 0.9% 1A8: 3.7%  In panel B, noninfected MLN and spleen show very low  
levels of background staining for parasite p30 (0.00212% in MLN and 0.00526% in  






































































Figure 4.2. Infection in the mesenteric lymph nodes and Peyer’s patches is         
not restricted to a specific population of cells. On day 5 and day 7  
after oral infection, mesenteric lymph nodes and Peyer’s patches were  
harvested, digested into single-cell suspensions, and stained for surface   
markers and parasites. The infected population was dominated by T  
and B lymphocytes at day 5 in both organs, but the infection in both organs  
on day 7 was evenly divided between Gr-1+ cells and lymphocytes.  
Infection rates per cell type (as defined by surface marker) are  as follows:  
Day 5 MLN B220: 0.4% CD3: 0.8% CD11c: 2.4% Gr-1: 2.2% CD11b:  
4.1% 1A8: 10% PP B220: 0.8% CD3: 1.4% CD11c: 3.7% Gr-1: 10%   
CD11b: 9.7% 1A8: 8.9% Day 7 MLN B220: 1.6% CD3: 5.0% CD11c: 8.2%  
Gr-1: 14. 7% CD11b: 13.1% 1A8: 14.6% PP B220: 5.6% CD3: 10.0% CD11c:  
14.3% Gr-1: 45.3% CD11b: 38.1% 1A8: 37.9% This experiment was repeated  





the rates of infection in CD11b, Gr-1, CD11c and 1A8-expressing cells were 4.1%, 
2.2%, 2.4% and 4.2%, respectively. This may indicate that although infection is 
promiscuous, innate immune cells, as defined by expression of CD11c, CD11b, Gr-1 
and/or 1A8, are preferred by the parasite. Peyer’s patches exhibited a similar pattern 
on day 5, with B220+ cells making up most of the infected population while innate 
immune cells showed a higher rate of infection, especially CD11b+ and Gr-1+ cells, 
which were infected at rates of 10% and 9.8% respectively, compared to the infection 
rate of 0.82% in B220+ cells. By day 7, innate immune cells accounted for more of the 
total cell population in both lymphoid sites, and represented about half of the total 
infected cells in lymph nodes, and nearly two-thirds in the Peyer’s patches. Overall, 
infection in the lymph nodes and Peyer’s patches appeared to favor cells expressing 
innate immune cell markers over lymphocytes; however, all cell types were invaded at 
these timepoints.  
 
MyD88 expression affects recruitment of dendritic cells and total infection rate, but 
not composition of the infected cell population. MyD88+/+ and MyD88-/- mice were 
infected with 100 cysts and mesenteric lymph nodes and Peyer’s patches were stained 
for flow cytometry on days 5 and 7. Infection rate in MyD88-/- animals was heavier at 
both timepoints, as about 0.3% of cells were infected in wild-type MLN compared to 
greater than 5% in the knockout, and 0.32% of cells were infected in wild-type Peyer’s 
patches compared to 1.27% in the knockouts (Figure 4.3 for day 7, data not shown for 
day 5). This confirmed previous results showing that parasite burden is higher in 
MyD88-deficient animals (24-25). Nevertheless, the absence of this signaling 



































































Figure 4.3. MyD88 expression does not affect infection of cells by T. gondii.         
MyD88+/+ and MyD88-/- mice were infected with 100 cysts, and mesenteric lymph  
nodes (MLN) and Peyer’s patches (PP) were isolated for flow cytometry 7 days  
post-infection. While MyD88-/- mice exhibited slight deficiency in recruitment of  
DC to these sites, the cell types comprising the infected population were not  
noticeably different in the absence of MyD88. Experiment was performed three  






signaling pathways are not a factor in parasite preference for particular cell types. 
However, at day 7 post-infection, there was a small but reproducible decrease in the 
dendritic cell population in the MLN of MyD88-/- mice, from 7.62% in wild-type 
lymph nodes to 3.28% in the MyD88-deficient animals. Over three experiments, the 
average decrease between wild-type and knockout mesenteric lymph nodes was 5.8 to 
3.01.   
 
1A8 cells are disproportionately parasitized in the lamina propria, and comprise half 
of the infected population. To examine infection in the lamina propria, I used two high 
doses of cysts, 500 and 1500 per mouse, as the 100 cyst dose yielded an extremely low 
percentage of infection in this tissue (Figure 4.4 and data not shown). Infection rate 
was too low to draw definitive conclusions from the 500 cyst dose. However, these 
results show a similar pattern to what is observed in the 1500 cyst dose. In both cases, 
the infected population was mostly divided between B220+ cells and 1A8+ cells. 
B220+ cells comprised 39%, and 1A8+ cells comprised 44% of the infected population 
after  the  500  cyst  infection,  while B220+ cells  accounted  for 41% of infected cells 
after the 1500 cyst dose, and 1A8+ cells for 30%. Although 60.8% of total LP cells 
express B220,  however,  less  than  7%  express  the  B  cell  marker CD19  (data  not 
shown), and none of the CD19-expressing cells harbor parasites, leaving the identity 
of the larger B220-expressing population, including the infected cells, ambiguous. 
Nevertheless, as B220+ cells are the dominant total population, their strong 
representation in the infected population was unsurprising. However, the strong 
presence of infected 1A8+ neutrophils, which comprised only 1% of the lamina propria             
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Figure 4.4. Infected cells in the lamina propria are mostly B220+ cells and  
neutrophils. Lamina propria from mice infected with 500 (A) or 1500 (B) cysts  
were harvested on day 4 post-infection, digested into a single-cell suspension and  
stained for surface markers and tachyzoites. 200,000 cells were collected for  
analysis. Dendritic cells and T cells were less strongly represented in the infected  
population, whereas neutrophils and B220+ cells were the major cell types  
parasitized. Infection rates per cell type as determined by surface marker are: 500  
cyst dose: B220: 0.007% CD3: 0.03% 1A8: 0.5% Gr-1: 0.9% CD11c: 0.15%  
CD11b: 0.9%  1500 cyst dose: B220: 0.1% CD3:.2% CD11b: 1.7% 1A8: 0.6% ‘ 
Gr-1: 1.4% CD11c: 0.8%  The 1500-cyst dose was repeated 3 times.  
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cells after a 500-cyst dose, and only 8% with 1500 cysts, was striking in comparison to 
the relatively non-preferential infection in the mesenteric lymph nodes and Peyer’s 
patches.  
 
Infected cells are located primarily in the lamina propria region. 
The method that I used to isolate lamina propria cells for FACS analysis requires 
removal of the epithelial cells, and therefore does not give a complete picture of the 
non-Peyer’s patch cells in the intestine. To determine whether epithelial cells were 
targets of infection, or whether infection was mostly located in the lamina propria, I 
infected mice for four days with 1500 cysts, and had sections of intestine stained for 
Toxoplasma by immunohistochemistry. My results showed parasite staining in the LP 
regions of the villi (Figure 4.5), and only infrequent staining in epithelial cells, 
confirming that the lamina propria was the primary location of infected cells on day 4 
post-inoculation.  
 
Evaluation of flow cytometry staining by immunofluorescence for CD3 
Digestion of the lamina propria for flow cytometry, while it can be a useful technique, 
also carries drawbacks. One of the primary difficulties with using this method for 
assessing populations of infected cells is the fact that the enzymes can digest surface 
molecules, leading to inaccurate results (26). The cells can recover their surface 
marker expression in culture, but culturing the cells carries the risk of parasites 
escaping the cells infected in the mouse, infecting other cells in culture, and rendering 
false results. My lamina propria preparations showed an unusually small population of 
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CD3+ cells, and I hypothesized that this may be due to the loss of surface molecules. 
To address this problem, I stained frozen intestinal tissue sections for CD3, to confirm 
whether the percentage of these cells that I observed by flow cytometry seemed 
comparable to the proportion in whole tissue. Previous characterizations of cell 
populations in the lamina propria have indicated that about 40% of the cells should be 
T lymphocytes (27). The immunofluorescence, like the flow cytometry data, did not 
show a majority of cells expressing CD3+ in either the proximal (Figure 4.6 A) or the 
distal (Figure 4.6 B) regions of the intestine. However, the proportion of CD3+ cells to 
total LP cells did appear to exceed the 6 to 10% that I had seen in my flow cytometry 
experiments, and therefore testing of shorter incubation times or different digestion 
enzymes may be desirable for optimizing the accuracy of the lamina propria flow data. 
 
Discussion  
Hijacking and manipulation of host cells by Toxoplasma gondii has been a topic of 
much investigation over the last several years. In vitro work in macrophages 
demonstrated that Toxoplasma infection can downregulate MHC Class II and block 
apoptosis (12-13, 16-17), and a recent study showed that natural killer cells are readily 
infected and resistant to lysis by uninfected NK cells afterward (11). These studies 
suggest that macrophages and NK cells could be reservoirs for the parasite. However, 
several studies point to modulation of motility and effector function in dendritic cells 
as indicators that T. gondii may use these cells as vehicles for silent dissemination 
throughout the body (21-23). My work with an intraperitoneal model of infection 
showed that Type I tachyzoites preferentially infect Gr-1-expressing DC compared to 
other  cell  types  in  the  peritoneal cavity, and suppress their ability to produce IL-12. 
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Figure 4.5. Parasites are mostly located in the lamina propria of the intestine. 
Intestines were harvested on day 4 post-infection, fixed in formalin, and embedded in 
paraffin for immunohistochemical staining. Staining for Toxoplasma was performed 
using rabbit anti-T. gondii serum. Patches of T. gondii staining (brown) are visible in 
the lamina propria regions of the villi. Parasite staining was infrequently observed in 
epithelial cells.  
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Figure 4.6. CD3+ cells are a substantial population in the proximal and distal 
sections of the intestine. Frozen intestinal tissue was cut into 8µM-thick tissue 
sections and stained with antibodies to CD3 (red) and DAPI (blue). Background 
staining with AlexaFluor 488 anti-mouse antibody is in green, and images are 
composites of sequential sections. CD3+ cells were visible in the proximal (A) and 
distal (B) regions of the intestine, but did not appear to comprise the majority of cells. 
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These DC migrate from the inoculation site to the spleen, where they are the primary 
population of infected cells. Later work revealed that Type II tachyzoites are also 
strongly associated with Gr-1-expressing DC in the spleen during acute infection, but 
that Type III parasites are not, possibly indicating that strain type determines whether 
tachyzoites use DCs for this purpose (Chapter 3).  
 
In this study, I used the oral model of infection with cysts of a Type II strain, ME49. 
The oral model, while not allowing as precise and consistent a dosage as the 
intraperitoneal route of infection, is an important one in T. gondii research, as it 
mimics the natural route of inoculation. The question of whether DC were Trojan 
horses not only in the intraperitoneal model, but also in the oral model, was therefore 
critical to discerning whether this phenomenon is relevant in natural infections. I 
examined several tissues from the gut, where bradyzoites transform into tachyzoites 
and begin their migration to other sites of the body. In lymphoid regions such as the 
mesenteric lymph nodes and Peyer’s patches, I found that innate immune cells had a 
higher frequency of infection than lymphocytes, but that lymphocytes comprised a 
greater percentage of the overall infected population, likely due to the fact that they 
were the major cell population in these tissues overall. This indicates that although T. 
gondii may exhibit a preference for innate immune cells, infection is promiscuous at 
early sites. Promiscuity at early sites of infection is consistent with my findings in the 
intraperitoneal model, where most cell types were infected in the peritoneal cavity.  
 
Interestingly, however, I found that infection was mostly restricted to two populations 
in the lamina propria: B220-expressing cells, and 1A8+ cells. I increased the infection 
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dose in order to produce a larger population of infected cells for visualization by 
immunofluorescence. I also noted that the CD3+ T lymphocyte population was 
unexpectedly small in my lamina propria preparations, as they typically represent 
almost half of the immune cells in this tissue (27). This result suggested to me that 
perhaps the long incubation of the lamina propria tissue in digestive enzymes was 
altering the expression of cell surface molecules, potentially leading to inaccurate 
results. However, this digestion was necessary to obtain a single-cell suspension for 
flow cytometry. Therefore, to confirm the validity of my flow data, I stained frozen 
sections of intestine for CD3. In contrast to the large numbers of CD3+ cells I expected 
to see, I found a minor population consistently throughout the intestine, mostly in the 
villi, and at similar levels in both the proximal and distal regions. Still, the proportion 
of CD3-expressing cells appeared to be higher than the proportion in my cell 
preparations for flow cytometry, indicating that further optimization of the digestion 
steps, including adjustment of time and perhaps varying the enzymes or enzyme 
concentrations, would be helpful. Additionally, further immunofluorescence would be 
desirable in order to determine the location of the infected neutrophils and B220+ 
cells.  
 
The preferential infection of neutrophils in the lamina propria raises the question of 
what role these cells are playing. In relation to the Trojan horse question, neutrophils 
have been observed to be important reservoirs for establishing infection with other 
intracellular pathogens, such as during infection with species of Leishmania (28-30). 
Parasites infect neutrophils, which produce macrophage inflammatory protein (MIP-
1β) and undergo apoptosis, and are then phagocytosed by the recruited macrophages 
where the parasite propagates (28). An alternative model has also been proposed in 
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which viable parasites are released from apoptotic neutrophils and then taken up by 
macrophages, but depletion of neutrophils impairs establishment of infection, 
implying that neutrophil infection or apoptosis is a critical step regardless (29). 
Nevertheless, depletion of neutrophils during Toxoplasma infection leads to higher 
parasite burden, which seems to rule out the possibility that a similar phenomenon is at 
work (31-32). Additionally, as-yet-unpublished results in our laboratory have 
confirmed the susceptibility of neutrophil-depleted mice using the neutrophil-specific 
antibody 1A8.  Therefore, further work will be necessary to determine the significance 
of the apparent preferential infection of neutrophils in the lamina propria, including 
examination of chemokines being produced to determine whether infected neutrophils 
attract other cells to assist in parasite dissemination, observation of whether 
neutrophils infected in this tissue kill parasites or whether parasites persist, and 
tracking of neutrophils to determine whether they migrate from the lamina propria 
once infected.   
 
Myeloid differentiation factor 88 (MyD88) plays a number of roles in T. gondii 
infection. As an adaptor molecule for Toll-like receptor signaling, it is involved in the 
induction of proinflammatory cytokines by recognition of Toxoplasma, and is 
therefore important for survival of infection. Knockout studies in mice show that in 
the absence of this molecule, animals show increased susceptibility to intraperitoneal 
and oral infection in that parasite replication is uncontrolled, and IL-12 production is 
defective in innate immune cells, with reduced levels of IL-12 overall in the blood 
(33). However, work with oral infections has shown that induction of adaptive 
immunity is independent of MyD88 (34). Additionally, infected MyD88 knockout 
mice display defective recruitment of neutrophils to the lamina propria after oral 
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inoculation and to the peritoneal cavity after intraperitoneal infection (34), implying 
that signaling through this molecule plays a part in determining what cells are present 
at the infection site. Therefore, MyD88 signaling may indirectly influence which cell 
types are targeted by tachyzoites. However, my work showed that there was no defect 
in cell recruitment to the mesenteric lymph nodes or Peyer’s patches on day 5 post-
infection, and while there was a reproducible defect in recruitment of CD11c+ DC to 
these regions on day 7, there did not appear to be major differences in the cell types 
targeted by the parasite. Therefore, MyD88 signaling does not appear to be involved in 
parasite preference for certain cell types.  
 
Previous studies with oral infections have suggested that CD11c+ cells are infected by 
tachyzoites shortly after infection in the lymphoid regions of the intestine. However, 
these studies were based on isolation of dendritic cells and subsequent PCR to test for 
the presence of parasites, a technique that could easily render misleading results if the 
dendritic cell isolation was not completely pure (22). My work using flow cytometry 
identifies infected cells more directly, and is therefore a more accurate picture of 
which cell types are targets of the parasite in these tissues. My work does not show 
preferential targeting of CD11c+ cells in the mesenteric lymph nodes, Peyer’s patches 
or lamina propria in the first week after infection, compared with other innate immune 
cells. However, studies have shown that Toxoplasma infection induces a state of 
hypermotility in dendritic cells, and that Type II parasites are the most efficient 
inducers of this increase in migration ability (21, 35). Therefore, although T. gondii 
may infect cells promiscuously in early tissues, this does not indicate that dendritic 
cells are not being used as Trojan horses; rather, it is possible that while all cell types 
get infected, dendritic cells are the only cell type in which increased migration is 
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promoted. Additionally, four days post-infection is likely too late to identify the very 
earliest targets of infection, as parasites have been detected in the intestine at 2 days 
post-infection (22). However, detecting very small numbers of infected cells at these 
early timepoints has proved technically challenging. Therefore, the possibility remains 
that the earliest cell targets may be dendritic cells, and this will require further study.  
 
This study has elucidated the cell types parasitized at the early sites of infection after 
oral inoculation, showing that T. gondii infects all cell types in the mesenteric lymph 
nodes and Peyer’s patches, and shows a preference for neutrophils in the lamina 
propria. Although these findings do not definitively point to a role for any cell type in 
enhancing the spread of Toxoplasma, they are useful in that this is the first study to 
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Summary of Findings 
Toxoplasma gondii infects mammals and birds by ingestion and is released from cysts 
into the intestinal tract as bradyzoites. Bradyzoites convert to tachyzoites and migrate 
to distant sites throughout the body before transforming into quiescent tissue cysts in 
the skeletal muscle and brain (1-5). An obligate intracellular parasite, T. gondii infects 
host cells and suppresses their proinflammatory cytokine production, ability to 
stimulate naïve T cells, and apoptosis pathways in order to evade killing by the 
immune system (6-11). Several in vitro and in vivo studies have attempted to elucidate 
whether T. gondii uses certain cell types as Trojan horses (12-13). In Chapter 2, I 
describe a population of Gr-1-expressing dendritic cells that are preferentially 
parasitized by T. gondii after intraperitoneal infection at the inoculation site, and 
comprise the majority of the infected cells in the spleen at day 4 post-infection. Using 
adoptive transfer with congenic mice, I demonstrate the ability of these infected DC to 
migrate from the peritoneal cavity to the spleen, and show with CCR2 knockout mice 
that the splenic population of CD11c+Gr-1+ cells is diminished, suggesting a role for 
this chemokine receptor in either the recruitment of these cells to the site of infection, 
or in migration from the infection site to the spleen. Finally, I cultured splenocytes 
with LPS and CpG and examined IL-12 production by flow cytometry, finding that T. 
gondii infection suppressed IL-12 induction in CD11c+Gr-1+ cells.  
 
The three major Toxoplasma strain types found in human infection in Europe and 
North America, Types I, II and III, show differences in growth rate and ability to 
modulate cytokine production, as well as in the ability to stimulate dendritic cell 
motility (14-17). In Chapter 3, I examined whether the preferential infection of Gr-1+ 
DC by Type I tachzyoites that I had noted in Chapter 2 was a strain-specific 
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phenomenon. I found that there were no significant differences between the strain 
types on day 5 post-infection in the spleen, with regard to which cells comprised the 
infected population. More work would be needed to determine whether Types II and 
III use this cell type for dissemination in the same manner as Type I, but these 
experiments did not demonstrate differences between strain types in terms of which 
cell populations are parasitized during acute infection in the spleen. I did, however, 
observe differences between strain types in the percentages of dendritic cells and 
neutrophils comprising the infected population at the inoculation site three days post-
infection, in that Type I-infected mice showed greater percentages of neutrophils in 
the infected population, and Type II- and Type III-infected mice showed greater 
percentages of DCs. This may indicate a difference in recruitment of cells to the 
infection site depending on strain type, or perhaps that all strain types preferentially 
infect DC, but the higher growth rate of Type I tachyzoites leads to lysis of infected 
DC prior to this timepoint.  
 
The intraperitoneal model of infection is a useful tool for keeping dosages consistent 
for T. gondii infection, as tachyzoites can be counted and delivered in precise 
quantities, whereas tissue cysts can contain varying numbers of bradyzoites, and 
therefore do not always give a consistent infection rate. Additionally, the 
intraperitoneal model allowed me to easily recover cells from the inoculation site. For 
the work described in Chapter 4, however, I wanted to assess the relevance of my 
work in the intraperitoneal model to the natural route of infection, which is simulated 
in the laboratory by delivery of tissue cysts to the stomach via oral gavage. I examined 
early sites of infection by flow cytometry, such as the lamina propria, the mesenteric 
lymph nodes and the Peyer’s patches, and determined that in the latter two regions, 
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infection appeared nonpreferential at days 3, 5 and 7 post-infection. All the immune 
cell populations that I examined were infected, and the largest total cell populations 
were also the most strongly represented cell types in the infected population; 
nevertheless, preferential infection may take place earlier in these regions. However, 
this was not the case in the lamina propria, where infected cells were mostly B220+ 
and 1A8+. I was concerned about the validity of my flow cytometry data, however, 
because the CD3+ population in my lamina propria preparations was unexpectedly 
low. Long enzymatic digestion of the tissue can destroy surface molecules (18), and so 
I sought to confirm the low numbers of CD3+ cells by immunofluorescence. I also 
used immunohistochemistry to confirm that only the lamina propria was infected, as I 
washed off the epithelial cells during preparation, and indeed found that epithelial 
cells were not targeted by Toxoplasma.  
 
Trojan horses during T. gondii infection 
The possibility that Toxoplasma gondii utilizes innate immune cells as safe havens or 
vehicles for dissemination is supported by a great deal of in vitro and in vivo evidence. 
The parasite not only prevents apoptosis in macrophages (10-11), but also diminishes 
the expression of the major histocompatibility complexes on macrophages and DC and 
prevents immature dendritic cells from upregulating CD40 (8-9), thereby avoiding 
antigen presentation. In vitro studies also showed the capacity of T. gondii to prevent 
TLR-triggered cytokine production by bone-marrow-derived macrophages (19-22). 
My work confirmed this latter finding, showing that IL-12 from splenic Gr-1-
expressing dendritic cells is diminished when these cells are parasitized during 
infection, suggesting that the parasite’s ability to block cytokine production induced 
by microbial stimuli is a relevant phenomenon during infection.  
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The downmodulation of immune functions in parasitized cells suggested the 
possibility that the Trojan horse phenomenon, in which intracellular pathogens hijack 
host cells for use in silent dissemination, is present in T. gondii infection. Previous 
studies showed evidence for dendritic cells as the target, showing that Toxoplasma 
infection increased the ability of bone-marrow-derived dendritic cells to cross 
endothelial cell monolayers in vitro, and transfer of infected DC to mice led to more 
rapid parasite dissemination in vivo (17). My work demonstrates that in an 
intraperitoneal infection model with Type I parasites, infected DC transferred via the 
peritoneal cavity do traffic to the spleen. This suggests that the large infected 
CD11c+Gr-1+ population that I observe in this organ on day 4 after infection is due to 
migration of parasitized cells from the inoculation site. When considered in 
conjunction with the studies showing increased DC motility after infection, this 
finding suggests that Toxoplasma hijacks dendritic cells specifically at the inoculation 
site to enhance its dissemination to other sites in the host.   
 
The differences in pathogenesis between strain types has been a topic of much 
research recently, as infection with different strains leads to distinct disease outcomes 
(23-25). Disparities in growth rate and cytokine suppression, two of the major strain 
differences, have been linked to recently-identified virulence factors (26-27), and a 
number of other strain variations have yet to be explained. For example, at low doses 
of infection, Type I tachyzoites induce greater influx of neutrophils to the inoculation 
site in intraperitoneal infection, whereas Type II parasites induce more Gr-1+ 
monocytes (28). My work showed a greater percentage of neutrophils on day 3 post-
inoculation with Type I parasites in the peritoneal cavity, but I also noted higher levels 
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of dendritic cells among the peritoneal exudate cells with Types II and III. While this 
may indicate that strain types induce recruitment of distinct cell populations, it may 
also simply be a result of the faster growth rate of Type I parasites, in that all strains 
may infect dendritic cells preferentially, but Type I lyses them prior to day 3.  
 
 
Previous work examining the cellular targets of T. gondii infection after oral 
inoculation with cysts has identified CD11c+ cells as targets in the mesenteric lymph 
nodes, and CD11c+ and CD11b+ cells as parasite-bearing cells in the blood and brain. 
(29). However, this study examined infection by isolating dendritic cells and 
performing PCR to determine infection, a method which is only as reliable as the 
purity of the cell preparations. My work using flow cytometry shows that after a dose 
of 100 cysts, most cell types are infected in the lymph nodes and Peyer’s patches on 
days 3, 5 and 7 post-infection, with lymphocytes, which are the largest populations in 
those sites, accounting for the largest populations of infected cells at days 3 and 5. 
This seems to suggest that at these timepoints, and at these sites, infection is not 
preferential. However, this does not rule out the possibility that preferential infection 
of DC takes place at other timepoints, or with different dosages of cysts.  
 
Infection of the lamina propria seems to be preferential toward 1A8+ cells, as these 
and B220+ cells comprise most of the infected population. Work in other models of 
infection with intracellular pathogens, including Leishmania major and Chlamydia 
pneumoniae, have proposed a role for neutrophils in establishing productive 
infections, allowing pathogens to silently enter and propagate in macrophages (30-31). 
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It is unlikely that this phenomenon occurs in Toxoplasma infection, as depletion of 
neutrophils with an anti-Gr-1 antibody leads to overwhelming parasite proliferation 
and therefore they do not seem to be necessary for establishment of infection (32). 
Caution must be exercised when interpreting this result, however, as Gr-1 is expressed 
on many other cell types, and therefore the lack of neutrophils is likely not the only 
factor in this enhanced susceptibility. Additionally, studies in our lab have shown that 
neutrophils stimulated with T. gondii release chemokines that are attractants for 
immature dendritic cells (33). Therefore, the possibility exists that neutrophils in the 
lamina propria, acting as parasite reservoirs, attract dendritic cells in order to infect 
them with tachyzoites, which then potentiate the dendritic cell migration to other 
areas.  
 
Future questions  
Several points still require study and clarification. Although I found fairly strong 
association of Type II parasites with CD11c+Gr-1+ cells in the spleen after 
intraperitoneal infection, this does not necessarily mean that the phenomenon I 
observed with Type I tachyzoites has been recapitulated. In order to gather more 
evidence that Type II parasites are also using this cell population as Trojan horses, I 
would need to perform at minimum an adoptive transfer experiment of Type II 
infected peritoneal cells into infected mice to determine whether they migrate to the 
spleen. Additionally, studying whether Type II parasites inhibit IL-12 production from 
these cells, as do Type I tachyzoites, would give further evidence for or against a 
Trojan horse hypothesis. The other major question raised by the strain comparison 
experiments is the reason behind the higher total percentages of DC at the infection 
site, and the higher percentage of DCs in the infected population, after inoculation 
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with Types II and III. There are two major possibilities, one of which is that Types II 
and III induce different chemokines than Type I, leading to greater recruitment of 
DCs, and that these parasites infect DC preferentially. The other possibility is that all 
strain types recruit and infect dendritic cells equally, and the disparity is simply the 
result of higher growth rate and faster lysis by Type I tachyzoites. The simplest 
approach to answering this question would be to harvest peritoneal cells on days 1 
through 3 post-infection, to determine whether dendritic cell levels with Type I are 
comparable to those during infection with Types II and III at earlier timepoints. 
Additionally, analysis of variations between strain types in terms of induction of 
chemokine production by peritoneal cells could point to differences in recruitment as 
well.  
 
A major question arising from the oral infection experiments is the rationale behind 
the preferential infection of neutrophils in the lamina propria. A small population of 
cells, they are nonetheless as strongly represented among infected cells as the largest 
total cell population, B220-expressing cells. Determining the reasons behind the 
apparent preference of Toxoplasma for infecting neutrophils will be necessary in order 
to decipher whether they play a role in dissemination. If neutrophils are acting as 
reservoirs for parasite and simultaneously recruiting immature DC, perhaps to act as 
vehicles for carrying the parasite elsewhere, depletion of neutrophils may diminish the 
levels of DC found in the lamina propria after infection, which could be examined by 
flow cytometry or immunofluorescence. Alternatively, comparing cell motility of 
isolated infected vs noninfected neutrophils would test the possibility that they are 
themselves disseminators of parasites.   
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In summary, I have elucidated a mechanism for dissemination by T. gondii in the 
intraperitoneal model of infection, observed differences in cell recruitment and 
targeting by varying strains of Toxoplasma, and have identified the early cellular 
targets of the parasite after oral inoculation. Several questions remain, and will need to 
be answered in order to determine whether DC are used as Trojan horses in different 
Toxoplasma strains as well as during oral infection, and what role neutrophils play as 
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